key: cord-0031363-wuj3xnqy
authors: Danel, Andrzej; Gondek, Ewa; Kucharek, Mateusz; Szlachcic, Paweł; Gut, Arkadiusz
title: 1H-Pyrazolo[3,4-b]quinolines: Synthesis and Properties over 100 Years of Research
date: 2022-04-26
journal: Molecules
DOI: 10.3390/molecules27092775
sha: a19bc7f7a79a351fbabb79f03f04b80717544bc4
doc_id: 31363
cord_uid: wuj3xnqy

This paper summarises a little over 100 years of research on the synthesis and the photophysical and biological properties of 1H-pyrazolo[3,4-b]quinolines that was published in the years 1911–2021. The main methods of synthesis are described, which include Friedländer condensation, synthesis from anthranilic acid derivatives, multicomponent synthesis and others. The use of this class of compounds as potential fluorescent sensors and biologically active compounds is shown. This review intends to summarize the abovementioned aspects of 1H-pyrazolo[3,4-b]quinoline chemistry. Some of the results that are presented in this publication come from the laboratories of the authors of this review.

1H-Pyrazolo [3,4-b] quinolines are three-membered azaheterocyclic systems that are composed of a pyrazole-and-quinoline fragment ( Figure 1 ). The parent structure can be modified with a number of substituents that have a great influence on the physical, photophysical and biological properties.

1H-Pyrazolo [3,4-b] quinolines are three-membered azaheterocyclic systems that are composed of a pyrazole-and-quinoline fragment ( Figure 1 ). The parent structure can be modified with a number of substituents that have a great influence on the physical, photophysical and biological properties. The first synthesis of this class of compounds was described in 1911 by Michaelis; however, the author incorrectly presented their structures. He concluded that the obtained compounds were a benzylidene derivative of 5-N-phenylamino-3-methyl-1-phenylpyrazole. This structure is marked in red in Figure 2 [1] . His results were later verified by other researchers. For this reason, the discoverer of this class of compounds should be considered as Niementowski and colleagues, who in their work presented the first structure of 1H-pyrazolo [3,4-b] quinoline in 1928 [2] . In the interwar period, there were some The first synthesis of this class of compounds was described in 1911 by Michaelis; however, the author incorrectly presented their structures. He concluded that the obtained compounds were a benzylidene derivative of 5-N-phenylamino-3-methyl-1-phenylpyrazole. This structure is marked in red in Figure 2 [1] . His results were later verified by other researchers. For this reason, the discoverer of this class of compounds should be considered as Niementowski and colleagues, who in their work presented the first structure of 1H-pyrazolo [3,4-b] quinoline in 1928 [2] . In the interwar period, there were some works by Koćwa, who also synthesised this system [3, 4] . The remaining works on the synthesis of these compounds were published after 1945. 

The Friedländer condensation of o-aminocarbonyl compounds 1 (R 3 = H, alkyl, aryl) with carbonyl systems that contain the active α-methylene group 2 is one of the most important methods of quinoline 3 synthesis [8] [9] [10] [11] [12] [13] (Figure 4 ) (Scheme 1). The reaction can be catalysed by acids and bases, but it also takes place in an inert environment. We start the description of synthetic PQ methods with the oldest results that were published by Niementowski and colleagues, who used the Friedländer condensation of anthranilaldehyde 4 and 5-methyl-2-phenyl-4H-pyrazol-3-one 5 (Scheme 2) [2] . As a result, three products were obtained: phenylhydrazone of 3-acetylquinolone 6; 3-methyl-1-phenyl-1H-pyrazolo [4,3- c]quinoline 7; and 3-(2-quinolyl)-quinolin-2-ol 8. The heating of phenylhydrazone 6 in the boiling of C 6 H 5 NO 2 led to the formation of 1-methyl-3-phenyl-1H-pyrazolo [3,4- b]quinoline 9. Thus, this compound can be described as the first synthesised pyrazoloquinoline. system increases the stiffness of the molecule and prevents packing and the intermolecular interactions in the film (after vacuum sputtering on the ITO anode), which hinders crystallisation and increases the Tg value. The tetrahedral nature of the carbon at the centre of the spiro of the system that links the two coupled systems serves as a breaking fragment for this coupling so that the optical and electronic properties of the system are preserved [19] .

Tao et al. synthesised two spiro PQs 16 systems by using the Friedländer condensation of o-aminobenzophenones on the basis of spirobifluorene 15 (Scheme 4) [20] . 

The previously mentioned Friedländer condensation procedures included either the appropriate aldehyde or ketone attached to a carbocyclic ring. One drawback of this synthesis is that the work of obtaining o-aminocarbonyl systems 1 is quite troublesome, and aldehydes are often not very stable reagents [21] . The reverse approach is also possible, where pyrazole o-aminoaldehyde 18 is used ( Figure 5 ) (Schemes 5 and 6). The reaction was re-examined by Tomasik and co-workers, and it turned out that compound 25 does not arise under these conditions. In the reaction mixture, only traces of two 1H-pyrazolo [3,4-b] quinolines were found: 1-phenyl-3-methyl-1H-pyrazolo [3,4b] quinoline (14; R 1 = Ph, R 2 = Me, R 3,4 = H) and 1-phenyl-3,4-methyl-1H-pyrazolo [3,4b] quinoline (14; R 1 = Ph, R 2,3 = Me, R 4 = H); however, both of them were formed as byproducts. 4-Hydroxy derivative 25 was not formed in this reaction. To prove it, the compound was obtained by another synthetic method, and it was compared to the obtained products by using TLC (Scheme 9); it was not detected in the reaction mixture, according to the Gosh procedure [27, 28] .

After studying a large number of publications on the synthesis of the compounds that are the subject of this review, it seems that, so far, it has not been possible to obtain pyrazoloquinolines by the direct reaction of anthranilic acid and pyrazolones.

On the other hand, anthranilic acid 23 and its derivatives, in turn, are a valuable substrate for the indirect synthesis of pyrazoloquinolines 29 (Scheme 9). Anthranilic acid 23 is reacted with diketene and acetic anhydride, which yields 2-acetonyl-4H-3,1-benzoxazin-4-one 26, which is easily separated from a reaction mixture by filtration. In the next step, 26 is converted to the pyrazole derivative 28 by reaction with the appropriate hydrazine. There is no need to isolate the intermediate 27. The final step in this reaction sequence is heating 28 in polyphosphoric acid (PPA) or phosphorus oxychloride (POCl3), depending on whether we want to obtain the 4-hydroxy derivative or the compound that contains the chlorine atom in the 4 position (29: R 2 = OH or R 2 = Cl). Scheme 8. An attempt to apply anthranilic acid for 4-hydroxy-1H-pyrazolo [3,4-b] quinoline synthesis.

The reaction was re-examined by Tomasik and co-workers, and it turned out that compound 25 does not arise under these conditions. In the reaction mixture, only traces of two 1H-pyrazolo [3,4-b] quinolines were found: 1-phenyl-3-methyl-1H-pyrazolo [3,4-b] quinoline (14; R 1 = Ph, R 2 = Me, R 3,4 = H) and 1-phenyl-3,4-methyl-1H-pyrazolo [3,4-b] quinoline (14; R 1 = Ph, R 2,3 = Me, R 4 = H); however, both of them were formed as byproducts. 4-Hydroxy derivative 25 was not formed in this reaction. To prove it, the compound was obtained by another synthetic method, and it was compared to the obtained products by using TLC (Scheme 9); it was not detected in the reaction mixture, according to the Gosh procedure [27, 28] . The reaction was re-examined by Tomasik and co-workers, and it turned out that compound 25 does not arise under these conditions. In the reaction mixture, only traces of two 1H-pyrazolo [3,4-b] quinolines were found: 1-phenyl-3-methyl-1H-pyrazolo [3,4b] quinoline (14; R 1 = Ph, R 2 = Me, R 3,4 = H) and 1-phenyl-3,4-methyl-1H-pyrazolo [3,4b] quinoline (14; R 1 = Ph, R 2,3 = Me, R 4 = H); however, both of them were formed as byproducts. 4-Hydroxy derivative 25 was not formed in this reaction. To prove it, the compound was obtained by another synthetic method, and it was compared to the obtained products by using TLC (Scheme 9); it was not detected in the reaction mixture, according to the Gosh procedure [27, 28] .

After studying a large number of publications on the synthesis of the compounds that are the subject of this review, it seems that, so far, it has not been possible to obtain pyrazoloquinolines by the direct reaction of anthranilic acid and pyrazolones.

On the other hand, anthranilic acid 23 and its derivatives, in turn, are a valuable substrate for the indirect synthesis of pyrazoloquinolines 29 (Scheme 9). Anthranilic acid 23 is reacted with diketene and acetic anhydride, which yields 2-acetonyl-4H-3,1-benzoxazin-4-one 26, which is easily separated from a reaction mixture by filtration. In the next step, 26 is converted to the pyrazole derivative 28 by reaction with the appropriate hydrazine. There is no need to isolate the intermediate 27. The final step in this reaction sequence is heating 28 in polyphosphoric acid (PPA) or phosphorus oxychloride (POCl3), depending on whether we want to obtain the 4-hydroxy derivative or the compound that contains the chlorine atom in the 4 position (29: R 2 = OH or R 2 = Cl). This reaction cycle was used by Stein et al. and by Crenshaw et al. to prepare 4-hydroxy and 4-chloro derivatives (29: R 2 = OH or Cl), which were then used to synthesize a whole range of compounds with biological activity, which will be discussed later in this After studying a large number of publications on the synthesis of the compounds that are the subject of this review, it seems that, so far, it has not been possible to obtain pyrazoloquinolines by the direct reaction of anthranilic acid and pyrazolones.

On the other hand, anthranilic acid 23 and its derivatives, in turn, are a valuable substrate for the indirect synthesis of pyrazoloquinolines 29 (Scheme 9). Anthranilic acid 23 is reacted with diketene and acetic anhydride, which yields 2-acetonyl-4H-3,1-benzoxazin-4-one 26, which is easily separated from a reaction mixture by filtration. In the next step, 26 is converted to the pyrazole derivative 28 by reaction with the appropriate hydrazine. There is no need to isolate the intermediate 27. The final step in this reaction sequence is heating 28 in polyphosphoric acid (PPA) or phosphorus oxychloride (POCl 3 ), depending on whether we want to obtain the 4-hydroxy derivative or the compound that contains the chlorine atom in the 4 position (29: R 2 = OH or R 2 = Cl).

This reaction cycle was used by Stein et al. and by Crenshaw et al. to prepare 4-hydroxy and 4-chloro derivatives (29: R 2 = OH or Cl), which were then used to synthesize a whole range of compounds with biological activity, which will be discussed later in this review [29, 30] . The 4-chloro derivatives 29 (R 2 = Cl) were then reacted with phenols, thiophenols and amines, which yielded phenoxy 29a, thiophenoxy 29b and amine-substituted 29c derivatives. These compounds showed antimalarial, antibacterial or interferon-inducing effects (Scheme 10). In the previous reaction, acetic anhydride was the reagent in one of several steps where anthranilic acid played an important role. On the other hand, Kim used it to cyclise N- (2-hydroxyphenyl) anthranilic acid 30, which resulted in two derivatives: 31 and a very small amount of 32 (1.7% yield). The reaction of 32 with hydrazine hydrate yielded a derivative of 1,9-dihydro-3-methyl-4H-pyrazolo [3,4-b] quinoline-4-one 33 (Scheme 11) [31] . In the previous reaction, acetic anhydride was the reagent in one of several steps where anthranilic acid played an important role. On the other hand, Kim used it to cyclise N-(2-hydroxyphenyl)anthranilic acid 30, which resulted in two derivatives: 31 and a very small amount of 32 (1.7% yield). The reaction of 32 with hydrazine hydrate yielded a derivative of 1,9-dihydro-3-methyl-4H-pyrazolo [3,4-b] quinoline-4-one 33 (Scheme 11) [31] .

In the previous reaction, acetic anhydride was the reagent in one of several steps where anthranilic acid played an important role. On the other hand, Kim used it to cyclise N- (2-hydroxyphenyl) anthranilic acid 30, which resulted in two derivatives: 31 and a very small amount of 32 (1.7% yield). The reaction of 32 with hydrazine hydrate yielded a derivative of 1,9-dihydro-3-methyl-4H-pyrazolo [3,4-b] quinoline-4-one 33 (Scheme 11) [31] . Scheme 11. N-Arylamide of anthranilic acid as a source for pyrazolo [3,4-b] quinoline synthesis.

In concluding the discussion of the use of anthranilic acid derivatives, one could also mention the publication of Gal et al., which concerns the transformation of the modified hydrazides of acid 34. Different products were formed, depending on the reaction conditions (e.g., 35). When the reaction was run in the presence of sodium ethoxide, the product was pyrazolo [3,4-b] quinoline 36 (Scheme 12) [32] . Scheme 11. N-Arylamide of anthranilic acid as a source for pyrazolo [3,4-b] quinoline synthesis.

In concluding the discussion of the use of anthranilic acid derivatives, one could also mention the publication of Gal et al., which concerns the transformation of the modified hydrazides of acid 34. Different products were formed, depending on the reaction conditions (e.g., 35). When the reaction was run in the presence of sodium ethoxide, the product was pyrazolo [3,4-b] quinoline 36 (Scheme 12) [32] . Contrary to the reaction that is shown in Scheme 10, the last two reactions (Schemes 11 and 12) have no preparative significance.

Path 2: C2,2: C4-C4a; N9-C8a ( Figure 5 ) As in the case of the Friedländer condensation, in this case as well, the derivatives of pyrazoles, such as 5-amino-1H-pyrazole-4-carboxylic acid derivatives 37, can be used. Pedersen obtained 4-N-phenyl-1H-pyrazolo [3,4-b] quinoline 40 by reacting pyrazole derivative 37, cyclohexanone 38 and aniline 39 in the presence of phosphorus pentoxide and N,N-dimethyl-N-cyclohexylamine. This reaction looks similar to a multicomponent one, but all of the atoms that make up the backbone matrix come only from 37 and 38. The next step was to oxidise 5,6,7,8-tetrahydro-1H-pyrazolo [3,4-b] quinolin-4-amine 40 to a fully aromatic 41 with 9,10-phenantrenoquinone 40a (Scheme 13) [33, 34] . Scheme 13. Synthesis of pyrazolo [3,4-b] quinoline based on ethyl ester of 3-amino-4-carboxyethylpyrazole.

One of the research groups, which was looking for new drugs for the treatment of Alzheimer's disease, prepared a series of 5,6,7,8-tetrahydropyrazolo[3,4-b]quinoline derivatives, such as 45 and 46, which were then transformed into other systems (e.g., 47) [35] . Aminopyrazoles 42 were prepared from the appropriate benzylhydrazines and eth-Scheme 12. Hydrazide of anthranilic acid as a precursor for pyrazolo [3,4-b] quinoline synthesis.

Contrary to the reaction that is shown in Scheme 10, the last two reactions (Schemes 11 and 12) have no preparative significance.

Path 2: C 2,2 : C4-C4a; N9-C8a ( Figure 5 ) As in the case of the Friedländer condensation, in this case as well, the derivatives of pyrazoles, such as 5-amino-1H-pyrazole-4-carboxylic acid derivatives 37, can be used. Pedersen obtained 4-N-phenyl-1H-pyrazolo [3,4-b] quinoline 40 by reacting pyrazole derivative 37, cyclohexanone 38 and aniline 39 in the presence of phosphorus pentoxide and N,N-dimethyl-N-cyclohexylamine. This reaction looks similar to a multicomponent one, but all of the atoms that make up the backbone matrix come only from 37 and 38. The next step was to oxidise 5,6,7,8-tetrahydro-1H-pyrazolo [3,4-b] quinolin-4-amine 40 to a fully aromatic 41 with 9,10-phenantrenoquinone 40a (Scheme 13) [33, 34] .

Path 1: C2 1 : C4-C3a; N9-C9a ( Figure 4 ) One of the classic named chemical reactions that leads to the quinoline system is the Pfitzinger synthesis [39, 40] . It uses isatin or its derivatives 50, which are easier to obtain than o-aminobenzaldehydes. The reaction is carried out in a basic environment, at which point the opening of the heterocyclic ring takes place to form a keto-acid 51, which is then condensed with aldehydes/ketones 2. Additionally, the final product, 52, can be decarboxylated (Scheme 16). The use of isatin 50 for the synthesis of pyrazolo [3,4-b] quinolines, where this system is built into the backbone, is very limited. One of the reactions is the synthesis that is reported by Fabrini [41] . A reaction between isatine 50 and 1,2-diphenylpyrazolidine-3,5dione 53 afforded 1H-pyrazolo [3,4-b] quinolin-3-one-4-carboxylic acid 54. In a similar fashion, Seshadri combined isatin 50 and 1,3-disubstituted pyrazolin-5-ones 10 under basic conditions and obtained 4-carboxylic acids 55, and with nitriles 56 after subsequent reactions of 55 with SOCl2 and P2O5 (Scheme 17) [42] . Recently, a few studies have appeared on multicomponent pyrazoloquinolines syntheses where isatins and their derivatives are used. The end product is the spiro-type systems, where isatin brings C-4 carbon to the overall structure. These reactions will be discussed in the final section on the synthesis of this class of compounds.

Another method of pyrazoloquinolines synthesis is the use of aromatic amines and 4 substituted pyrazole derivatives such as aldehydes, ketones or benzylidene ones ( Figure  6 ). The use of isatin 50 for the synthesis of pyrazolo [3,4-b] quinolines, where this system is built into the backbone, is very limited. One of the reactions is the synthesis that is reported by Fabrini [41] . A reaction between isatine 50 and 1,2-diphenylpyrazolidine-3,5-dione 53 afforded 1H-pyrazolo [3,4-b] quinolin-3-one-4-carboxylic acid 54. In a similar fashion, Seshadri combined isatin 50 and 1,3-disubstituted pyrazolin-5-ones 10 under basic conditions and obtained 4-carboxylic acids 55, and with nitriles 56 after subsequent reactions of 55 with SOCl 2 and P 2 O 5 (Scheme 17) [42] . The use of isatin 50 for the synthesis of pyrazolo [3,4-b] quinolines, where this system is built into the backbone, is very limited. One of the reactions is the synthesis that is reported by Fabrini [41] . A reaction between isatine 50 and 1,2-diphenylpyrazolidine-3,5dione 53 afforded 1H-pyrazolo [3,4-b] quinolin-3-one-4-carboxylic acid 54. In a similar fashion, Seshadri combined isatin 50 and 1,3-disubstituted pyrazolin-5-ones 10 under basic conditions and obtained 4-carboxylic acids 55, and with nitriles 56 after subsequent reactions of 55 with SOCl2 and P2O5 (Scheme 17) [42] . Recently, a few studies have appeared on multicomponent pyrazoloquinolines syntheses where isatins and their derivatives are used. The end product is the spiro-type systems, where isatin brings C-4 carbon to the overall structure. These reactions will be discussed in the final section on the synthesis of this class of compounds. [3,4-b] quinoline Syntheses Based on 5-chloro-4-aroyl/formylpyrazoles and 4benzylidene-1,3-disubstituted-pyrazol-5-ones

Another method of pyrazoloquinolines synthesis is the use of aromatic amines and 4 substituted pyrazole derivatives such as aldehydes, ketones or benzylidene ones ( Figure  6 ). Recently, a few studies have appeared on multicomponent pyrazoloquinolines syntheses where isatins and their derivatives are used. The end product is the spiro-type systems, where isatin brings C-4 carbon to the overall structure. These reactions will be discussed in the final section on the synthesis of this class of compounds. [3,4-b] quinoline Syntheses Based on 5-chloro-4-aroyl/formylpyrazoles and 4-benzylidene-1,3-disubstituted-pyrazol-5-ones Another method of pyrazoloquinolines synthesis is the use of aromatic amines and 4 substituted pyrazole derivatives such as aldehydes, ketones or benzylidene ones ( Figure 6 ).

theses where isatins and their derivatives are used. The end product is the tems, where isatin brings C-4 carbon to the overall structure. These reactio cussed in the final section on the synthesis of this class of compounds. [3,4-b] quinoline Syntheses Based on 5-chloro-4-aroyl/formylpyra benzylidene-1,3-disubstituted-pyrazol-5-ones Another method of pyrazoloquinolines synthesis is the use of aromati substituted pyrazole derivatives such as aldehydes, ketones or benzyliden 6). In 1963, Brack published a work on the synthesis of pyrazoloquinolines that was based on the reactions of aromatic amines 39 and 5-chloro-4-formylpyrazoles 58 [43, 44] . The latter compounds were obtained by the formylation of the appropriate 5-chloropyrazoles 57 [45] . They can also be obtained in one step in the Vilsmeier-Haack reaction by treating the pyrazolones 10 with a DMF / POCl 3 mixture [46] . The original Brack's reaction was carried out in melt within 110-150 • C (Scheme 18). In 1963, Brack published a work on the synthesis of pyrazoloquinolines that was based on the reactions of aromatic amines 39 and 5-chloro-4-formylpyrazoles 58 [43, 44] . The latter compounds were obtained by the formylation of the appropriate 5-chloropyrazoles 57 [45] . They can also be obtained in one step in the Vilsmeier-Haack reaction by treating the pyrazolones 10 with a DMF / POCl3 mixture [46] . The original Brack's reaction was carried out in melt within 110-150 °C (Scheme 18). Scheme 18. Synthesis of 1H-pyrazolo [3,4-b] quinolines, according to Brack's protocol.

Two possible schemes for this reaction have been found in the literature. One was proposed by Brack (Scheme 19) . The reaction starts from the formation of Schiff base 58a from aniline 39 and aldehyde 58. In the next steps, several rearrangements take place with the formation of the final pyrazoloquinoline 59. Scheme 18. Synthesis of 1H-pyrazolo [3,4-b] quinolines, according to Brack's protocol.

Two possible schemes for this reaction have been found in the literature. One was proposed by Brack (Scheme 19) . The reaction starts from the formation of Schiff base 58a from aniline 39 and aldehyde 58. In the next steps, several rearrangements take place with the formation of the final pyrazoloquinoline 59.

Another mechanism was proposed a few years ago that consists of the nucleophilic substitution of the chlorine atom in pyrazole 58 by an amino group in 39 with subsequent ring formation, and the elimination of the water molecule and hydrogen cation, which leads to the aromatisation of the system (intermediates 60-61b) (Scheme 20) [47] . It seems, however, that the experimental data support the former; therefore, it was possible to isolate the intermediate product, which was Schiff's base 58a, which was formed from pyrazole aldehyde 58 and substituted aniline 39. The authors of the later paper were not able to isolate amine derivative 60. Scheme 18. Synthesis of 1H-pyrazolo [3,4-b] quinolines, according to Brack's protocol.

Two possible schemes for this reaction have been found in the literature. One w proposed by Brack (Scheme 19) . The reaction starts from the formation of Schiff base 5 from aniline 39 and aldehyde 58. In the next steps, several rearrangements take place w the formation of the final pyrazoloquinoline 59. Scheme 19. The possible mechanism of Brack's synthesis.

Another mechanism was proposed a few years ago that consists of the nucleoph substitution of the chlorine atom in pyrazole 58 by an amino group in 39 with subsequ ring formation, and the elimination of the water molecule and hydrogen cation, wh leads to the aromatisation of the system (intermediates 60-61b) (Scheme 20) [47] . It seems, however, that the experimental data support the former; therefore, it was possible to isolate the intermediate product, which was Schiff's base 58a, which was formed from pyrazole aldehyde 58 and substituted aniline 39. The authors of the later paper were not able to isolate amine derivative 60. Scheme 20. An alternative mechanism of Brack's 1H-pyrazolo [3,4-b] quinoline synthesis.

In the original work of Brack, the author limited himself mainly to three 5-chloro-4formylpyrazole aldehydes (58; R 1 = Me, R 2 = Ph; R 1 = Ph, R 2 = Me; R 1 = tetrahydro-1,1-dioxo-3-thienyl, R 2 = Me) and a few aromatic amines. However, this reaction has many more possibilities, as is shown in several later works by other authors [48] . The use of 5-chloro-4-aroylpyrazoles 64 is an extension of the scope of two-component reactions with aromatic amines R 4 C6H4NH2 and pyrazole systems with aldehyde function 58 [49] (Scheme 21). Scheme 20. An alternative mechanism of Brack's 1H-pyrazolo [3,4-b] quinoline synthesis.

In the original work of Brack, the author limited himself mainly to three 5-chloro-4formylpyrazole aldehydes (58; R 1 = Me, R 2 = Ph; R 1 = Ph, R 2 = Me; R 1 = tetrahydro-1,1dioxo-3-thienyl, R 2 = Me) and a few aromatic amines. However, this reaction has many more possibilities, as is shown in several later works by other authors [48] . The use of 5-chloro-4-aroylpyrazoles 64 is an extension of the scope of two-component reactions with aromatic amines R 4 C 6 H 4 NH 2 and pyrazole systems with aldehyde function 58 [49] (Scheme 21). Scheme 20. An alternative mechanism of Brack's 1H-pyrazolo [3,4-b] quinoline synthesis.

In the original work of Brack, the author limited himself mainly to three 5-chloro-4formylpyrazole aldehydes (58; R 1 = Me, R 2 = Ph; R 1 = Ph, R 2 = Me; R 1 = tetrahydro-1,1-dioxo-3-thienyl, R 2 = Me) and a few aromatic amines. However, this reaction has many more possibilities, as is shown in several later works by other authors [48] . The use of 5-chloro-4-aroylpyrazoles 64 is an extension of the scope of two-component reactions with aromatic amines R 4 C6H4NH2 and pyrazole systems with aldehyde function 58 [49] (Scheme 21).

Synthesis of 1H-pyrazolo [3,4-b] quinolines based on 4-aroyl-5-chloropyrazoles.

Pyrazole derivatives 64 can be synthesised either by the acylation of 5-chloropyrazoles with aromatic acid chlorides 62 and aluminum chloride, or by reacting pyrazolones Scheme 21. Synthesis of 1H-pyrazolo [3,4-b] quinolines based on 4-aroyl-5-chloropyrazoles.

Pyrazole derivatives 64 can be synthesised either by the acylation of 5-chloropyrazoles with aromatic acid chlorides 62 and aluminum chloride, or by reacting pyrazolones 10 and acid chlorides 62, followed by chlorination with phosphorus oxychloride [50] (Scheme 21). In contrast to the reaction with aldehydes 58, this reaction required much more severe conditions and it lasted from 2 to 3 h at 220 • C. In one case, the authors isolated an intermediate product, which was the product of the nucleophilic amine substitution of the aromatic chlorine atom at the 5 position of the pyrazole ring. This proves a different mechanism than in the case of the original Brack reaction with pyrazole aldehyde 58 (Scheme 19) , and it would, in a way, confirm the mechanism that was proposed for this reaction by Wan et al. (Scheme 20) [50] .

Gonzales and El Guero probably describe the only reaction where the 4 acetyl derivatives of chloropyrazole 66 and phenylhydrazine 67 were used for the synthesis of pyrazoloquinoline 69. Depending on the reaction conditions, either the corresponding phenylhydrazone 68 or pyrazoloquinoline 69 are obtained. In the latter case, the authors suggest that phenylhydrazine decomposes under the influence of high temperatures, and the resulting aniline reacts with the chlorine atom with subsequent cyclisation to pyrazoloquinoline [51] 10 and acid chlorides 62, followed by chlorination with phosphorus oxychloride [50] (Scheme 21). In contrast to the reaction with aldehydes 58, this reaction required much more severe conditions and it lasted from 2 to 3 h at 220 °C. In one case, the authors isolated an intermediate product, which was the product of the nucleophilic amine substitution of the aromatic chlorine atom at the 5 position of the pyrazole ring. This proves a different mechanism than in the case of the original Brack reaction with pyrazole aldehyde 58 (Scheme 19) , and it would, in a way, confirm the mechanism that was proposed for this reaction by Wan et al. (Scheme 20) [50] . Gonzales and El Guero probably describe the only reaction where the 4 acetyl derivatives of chloropyrazole 66 and phenylhydrazine 67 were used for the synthesis of pyrazoloquinoline 69. Depending on the reaction conditions, either the corresponding phenylhydrazone 68 or pyrazoloquinoline 69 are obtained. In the latter case, the authors suggest that phenylhydrazine decomposes under the influence of high temperatures, and the resulting aniline reacts with the chlorine atom with subsequent cyclisation to pyrazoloquinoline [51] (Scheme 22).

Reaction of phenylhydrazine with 4-acetyl-5-chloro-3-methyl-1-phenylpyrazole.

Crenshaw et al. synthesised 10H-pyrido [2,3-h] pyrazolo [3,4-b] quinoline 73 by starting from 5-aminoquinoline 70 and 5-chloro-1,3-dimethylpyrazolo-4-carboxylic acid 71 [52] (Scheme 23). The purpose of this reaction was to confirm the structure of product 73 that was unexpectedly formed by the ring closure of the derivative 28 [3,4-b] quinoline 73 by starting from 5-aminoquinoline 70 and 5-chloro-1,3-dimethylpyrazolo-4-carboxylic acid 71 [52] (Scheme 23). The purpose of this reaction was to confirm the structure of product 73 that was unexpectedly formed by the ring closure of the derivative 28 (R 1 = Me, R = 4-NO 2 ), instead of the expected 4-chloro-7-nitro-1,3-dimethyl-1H-pyrazolo [3,4-b] quinoline 29 (R 1 = Me, R 2 = Cl, R = 7-NO 2 ) (Scheme 9).

Reaction of phenylhydrazine with 4-acetyl-5-chloro-3-methyl-1-phenylpyrazole.

Crenshaw et al. synthesised 10H-pyrido [2,3-h] pyrazolo [3,4-b] quinoline 73 by starting from 5-aminoquinoline 70 and 5-chloro-1,3-dimethylpyrazolo-4-carboxylic acid 71 [52] (Scheme 23). The purpose of this reaction was to confirm the structure of product 73 that was unexpectedly formed by the ring closure of the derivative 28 (R 1 = Me, R = 4-NO2), instead of the expected 4-chloro-7-nitro-1,3-dimethyl-1H-pyrazolo [3,4-b] quinoline 29 (R 1 = Me, R 2 = Cl, R = 7-NO2) (Scheme 9).

Regardless of the analysis of the structure of compound 73 by using the 1 [3,4-b] quinolines that uses anilines 39 and benzylidene derivatives 74 (Scheme 24). This reaction produces derivatives that are substituted with a phenyl group (or a substituted phenyl group) in position 4 of the parent backbone 65. As a side product, compound 75 was isolated. It is an excellent alternative to Friedländer condensation, where 2-aminobenzophenones 1 (R 3 = Ph) are used (Scheme 3) [1, 53] . Scheme 24. Synthesis of pyrazolo [3,4-b] quinolines from 4-benzylidenepyrazol-3-ones and anilines.

While searching for the literature on the synthesis of pyrazoloquinolines, we came across a work where a whole series of syntheses of various pyrazole derivatives with potential biological effects were described [54] . Among them was the synthesis that uses the benzylidene derivative 74 (R 1 = Ph, R 2 = Me, R 3 = p-OMe) and 1,4-phenylenediamine 39 (R 4 = p-NH2) (Scheme 24). The authors took into account the possibility of the formation of a condensed 76 system, but they did not find it in the reaction products. They only describe that they received compound 77, which was supposed to be a pyrazoloquinoline and a Scheme 24. Synthesis of pyrazolo [3,4-b] quinolines from 4-benzylidenepyrazol-3-ones and anilines.

While searching for the literature on the synthesis of pyrazoloquinolines, we came across a work where a whole series of syntheses of various pyrazole derivatives with potential biological effects were described [54] . Among them was the synthesis that uses the benzylidene derivative 74 (R 1 = Ph, R 2 = Me, R 3 = p-OMe) and 1,4-phenylenediamine 39 (R 4 = p-NH 2 ) (Scheme 24). The authors took into account the possibility of the formation of a condensed 76 system, but they did not find it in the reaction products. They only describe that they received compound 77, which was supposed to be a pyrazoloquinoline and a side product 78. However, they did not provide evidence of this in the form of 1 H NMR and 13 C NMR spectra for both of them. The obtained substance (77) was white, which is in contradiction to our research to date. We have obtained a whole range of variously substituted 1,4-diphenyl-3-methyl-1H-pyrazoloquinolines, which are always yellow crystalline substances, and are, in addition, also strongly fluorescing, which the authors of the publication did not mention. Thus, it seems to us that they failed to obtain 77.

The procedure that was developed by Brack is an extremely effective tool for the synthesis of pyrazoloquinolines. There is also the possibility of using substituted o-halogenobenzoic aldehydes and aminopyrazoles ( Figure 7 ). crystalline substances, and are, in addition, also strongly fluorescing, which the authors of the publication did not mention. Thus, it seems to us that they failed to obtain 77.

The procedure that was developed by Brack is an extremely effective tool for the synthesis of pyrazoloquinolines. There is also the possibility of using substituted o-halogenobenzoic aldehydes and aminopyrazoles ( Figure 7 ). [55] (Scheme 25). The authors focused on regioselective reactions, which would allow the preparation of mono-and disubstituted pyrazoloquinoline halogen derivatives, which could be used later for further reactions (e.g., nucleophilic substitution with aliphatic or aromatic amines), and which could be used, for example, as luminophores for the construction of electroluminescent cells. Scheme 25. Synthesis of pyrazolo [3,4-b] quinolines from 3-aminopyrazoles and halogenated aromatic aldehydes.

In the case of monosubstituted aldehydes 79 (R 3,4 = H, X = F, Cl, Br, I), it has been observed that, besides pyrazoloquinoline 80, bis-pyrazolo [3,4-b ;3′,4′-e]pyridine 81 is also formed; however, in the case of o-fluorobenzaldehyde, pyrazoloquinoline was the final product. The opposite tendency was observed for o-iodobenzaldehyde 79 (R 3,4 = H, X = I). Pentafluorobenzaldehyde yielded only pyrazoloquinoline 80. As part of the work, the influence of the base on the course of the reaction was also investigated, and it turned out that bases such as DABCO or quinoline favored the formation of 80 but not of 81.The influence of the substituents in the aminopyrazole 17 was also of some importance, and so the system with the phenyl group in position 3 (17; R 2 = Ph) favored the formation of [55] (Scheme 25). The authors focused on regioselective reactions, which would allow the preparation of mono-and disubstituted pyrazoloquinoline halogen derivatives, which could be used later for further reactions (e.g., nucleophilic substitution with aliphatic or aromatic amines), and which could be used, for example, as luminophores for the construction of electroluminescent cells. crystalline substances, and are, in addition, also strongly fluorescing, which the authors of the publication did not mention. Thus, it seems to us that they failed to obtain 77.

The procedure that was developed by Brack is an extremely effective tool for the synthesis of pyrazoloquinolines. There is also the possibility of using substituted o-halogenobenzoic aldehydes and aminopyrazoles ( Figure 7 ). [55] (Scheme 25). The authors focused on regioselective reactions, which would allow the preparation of mono-and disubstituted pyrazoloquinoline halogen derivatives, which could be used later for further reactions (e.g., nucleophilic substitution with aliphatic or aromatic amines), and which could be used, for example, as luminophores for the construction of electroluminescent cells. In the case of monosubstituted aldehydes 79 (R 3,4 = H, X = F, Cl, Br, I), it has been observed that, besides pyrazoloquinoline 80, bis-pyrazolo [3,4- Pentafluorobenzaldehyde yielded only pyrazoloquinoline 80. As part of the work, the influence of the base on the course of the reaction was also investigated, and it turned out that bases such as DABCO or quinoline favored the formation of 80 but not of 81.The influence of the substituents in the aminopyrazole 17 was also of some importance, and so the system with the phenyl group in position 3 (17; R 2 = Ph) favored the formation of PQ, while the methyl group contributed to the formation of more 81. Dehaen et al. investigated the reaction pentafluorobenzaldehyde and 5-chloro-4-formylpyrazoles 17 with 5-amino-1,2-azoles. Depending on the reaction conditions, the positions of the halogen atom in relation to the carbonyl group pyrazolo [3,4-b] quinolines 80, bis-pyrazolo[3,4-b; 4 ,3 -e]pyridines 81 and isoxazolo [5,4-b] quinolines were formed [56] .

Another reaction route is the use of o-halogen-substituted benzoic acids 82 and 1,3-disubstituted 5-aminopyrazoles 17. As a result of the Ullmann-type reaction that is catalysed by copper, an intermediate 83 is formed. In the next step, it can be transformed into 84 by heating with POCl 3 (Scheme 26). This reaction was used, inter alia, by Siminoff and other researchers for the synthesis of 84 from anthranilic acid 23 and diketene [34, 57, 58] Another reaction route is the use of o-halogen-substituted benzoic acids 82 and 1,3disubstituted 5-aminopyrazoles 17. As a result of the Ullmann-type reaction that is catalysed by copper, an intermediate 83 is formed. In the next step, it can be transformed into 84 by heating with POCl3 (Scheme 26). This reaction was used, inter alia, by Siminoff and other researchers for the synthesis of 84 from anthranilic acid 23 and diketene [34, 57, 58] (Scheme 9). The ratio of the products that were obtained depended on the conditions under which the reaction was carried out. Thus, during heating at 120 °C for 24 h, the Schiff's base 88 dominated in the reaction mixture, while the reaction that was carried out in the microwave field, without a solvent, for 15 min, favored the formation of pyrazoloquinoline 87. As a catalyst, 2.5 mol% palladium acetate has been proven to be the best.

At the end of the description of the use of the o-halogen derivatives of acids, esters and aldehydes, we want to mention the use of a benzyl alcohol derivative that has been cyclised to pyrazoloquinoline. In 1974, Horace de Wald synthesised a series of pyrazoloquinolines 93 as potential antidepressants [60] . As a starting material, he applied the methyl ester of 2-chlorobenzoic acid 89. The Ullmann reaction with 1,3-dimethyl-5-amino pyrazole 17 afforded the formation of 90. This compound was reacted with Grignard reagent CH3MgBr, and it was hydrolysed to yield an alcohol 91, which was cyclised to 92 with PPA at 85-110 °C (Scheme 28). Another reaction route is the use of o-halogen-substituted benzoic acids 82 and 1,3disubstituted 5-aminopyrazoles 17. As a result of the Ullmann-type reaction that is catalysed by copper, an intermediate 83 is formed. In the next step, it can be transformed into 84 by heating with POCl3 (Scheme 26). This reaction was used, inter alia, by Siminoff and other researchers for the synthesis of 84 from anthranilic acid 23 and diketene [34, 57, 58] (Scheme 9). The ratio of the products that were obtained depended on the conditions under which the reaction was carried out. Thus, during heating at 120 °C for 24 h, the Schiff's base 88 dominated in the reaction mixture, while the reaction that was carried out in the microwave field, without a solvent, for 15 min, favored the formation of pyrazoloquinoline 87. As a catalyst, 2.5 mol% palladium acetate has been proven to be the best.

At the end of the description of the use of the o-halogen derivatives of acids, esters and aldehydes, we want to mention the use of a benzyl alcohol derivative that has been cyclised to pyrazoloquinoline. In 1974, Horace de Wald synthesised a series of pyrazoloquinolines 93 as potential antidepressants [60] . As a starting material, he applied the methyl ester of 2-chlorobenzoic acid 89. The Ullmann reaction with 1,3-dimethyl-5-amino pyrazole 17 afforded the formation of 90. This compound was reacted with Grignard reagent CH3MgBr, and it was hydrolysed to yield an alcohol 91, which was cyclised to 92 with PPA at 85-110 °C (Scheme 28). The ratio of the products that were obtained depended on the conditions under which the reaction was carried out. Thus, during heating at 120 • C for 24 h, the Schiff's base 88 dominated in the reaction mixture, while the reaction that was carried out in the microwave field, without a solvent, for 15 min, favored the formation of pyrazoloquinoline 87. As a catalyst, 2.5 mol% palladium acetate has been proven to be the best.

At the end of the description of the use of the o-halogen derivatives of acids, esters and aldehydes, we want to mention the use of a benzyl alcohol derivative that has been cyclised to pyrazoloquinoline. In 1974, Horace de Wald synthesised a series of pyrazoloquinolines 93 as potential antidepressants [60] . As a starting material, he applied the methyl ester of 2-chlorobenzoic acid 89. The Ullmann reaction with 1,3-dimethyl-5amino pyrazole 17 afforded the formation of 90. This compound was reacted with Grignard reagent CH 3 MgBr, and it was hydrolysed to yield an alcohol 91, which was cyclised to 92 with PPA at 85-110 • C (Scheme 28). 

The most common way to obtain pyrazolo [3,4-b] quinolines by using the fifth path is by the reaction of the hydrazines RNHNH2 (R = H, aryl) with quinoline derivatives ( Figure  8 ). 

The most common way to obtain pyrazolo [3,4-b] quinolines by using the fifth path is by the reaction of the hydrazines RNHNH 2 (R = H, aryl) with quinoline derivatives (Figure 8 ). 

The most common way to obtain pyrazolo [3,4-b] quinolines by using the fifth by the reaction of the hydrazines RNHNH2 (R = H, aryl) with quinoline derivatives 8). 

The most common way to obtain pyrazolo [3,4-b] quinolines by using the fift by the reaction of the hydrazines RNHNH2 (R = H, aryl) with quinoline derivatives 8). The resulting compound, 5-chloro-4-formylquinoline 95, can be transformed into a wide variety of fused heterocyclic derivatives, including 1H-or 2H-pyrazolo [3,4-b] quinolines ( Figure 9 ) [64] . In the next turn, the aldehyde group was protected by transformation into acetal 105 and was reacted with methylhydrazine 97 or hydrazine 96, which formed compound 106. This one was heated in boiling ethanol that was acidified with HCl, which afforded 10-methyl-10H-benzo[h]pyrazolo [3,4-b] quinoline 107 (Scheme 31) [76] . These derivatives were synthesised as potential topoisomerase inhibitors. In the next turn, the aldehyde group was protected by transformation into acetal 105 and was reacted with methylhydrazine 97 or hydrazine 96, which formed compound 106. This one was heated in boiling ethanol that was acidified with HCl, which afforded 10-methyl-10H-benzo[h]pyrazolo [3,4-b] quinoline 107 (Scheme 31) [76] . These derivatives were synthesised as potential topoisomerase inhibitors. When 2-naphthylamine 108 is used instead of 1-naphthylamine, the aldehyde 110 can be obtained by carrying out the same chemical transformations (e.g., acetyl derivative 109) as for the previously described reactions. Maheira converted 109 into an oxime by reaction with hydroxylamine hydrochloride and, with the subsequent treatment with SOCl2 in boiling benzene, he obtained 2-chloro-benzo[g]quinoline-3-carbonitrile 111. Further reaction with hydrazine 96 gave 112. In the next turn, 3-aminoderivative 112 was coupled with various pyrazol-5-ones, which formed a series of azo dyes for polyester fibers (Scheme 32) [77, 78] . The same synthetic protocol can be used for 95 by the transformation of it into oxime, 2-chloroquinoline-3-carbonitrile and then into 3-amino-1H-pyrazolo [3,4-b] quinoline, which is then modified in various ways to search for potential compounds of biological activity (Scheme 32-structures marked in blue) [79] . Section 2.5 discusses the few cases where isatin and pyrazolones are used in the Pfitzinger reaction for the synthesis of pyrazoloquinolines. Here, we have another one of the few cases that uses this compound, and specifically its derivative 113, which is formed as a result of the reaction of isatin 50 with ethyl cyanoacetate. The reaction with ethanol acidified with sulphuric acid afforded ethyl 3-cyano-2-oxo-1,2-dihydroquinoline-4-carboxylate 114. Heating with a mixture of phosphorus oxychloride and phosphorus trichloride When 2-naphthylamine 108 is used instead of 1-naphthylamine, the aldehyde 110 can be obtained by carrying out the same chemical transformations (e.g., acetyl derivative 109) as for the previously described reactions. Maheira converted 109 into an oxime by reaction with hydroxylamine hydrochloride and, with the subsequent treatment with SOCl 2 in boiling benzene, he obtained 2-chloro-benzo[g]quinoline-3-carbonitrile 111. Further reaction with hydrazine 96 gave 112. In the next turn, 3-aminoderivative 112 was coupled with various pyrazol-5-ones, which formed a series of azo dyes for polyester fibers (Scheme 32) [77, 78] . When 2-naphthylamine 108 is used instead of 1-naphthylamine, the aldehyde 11 be obtained by carrying out the same chemical transformations (e.g., acetyl derivative as for the previously described reactions. Maheira converted 109 into an oxime by rea with hydroxylamine hydrochloride and, with the subsequent treatment with SOC boiling benzene, he obtained 2-chloro-benzo[g]quinoline-3-carbonitrile 111. Further tion with hydrazine 96 gave 112. In the next turn, 3-aminoderivative 112 was coupled various pyrazol-5-ones, which formed a series of azo dyes for polyester fibers (Schem [77, 78] .

The same synthetic protocol can be used for 95 by the transformation of it into ox 2-chloroquinoline-3-carbonitrile and then into 3-amino-1H-pyrazolo [3,4-b] quino which is then modified in various ways to search for potential compounds of biolo activity (Scheme 32-structures marked in blue) [79] . Section 2.5 discusses the few cases where isatin and pyrazolones are used in the P inger reaction for the synthesis of pyrazoloquinolines. Here, we have another one o few cases that uses this compound, and specifically its derivative 113, which is form a result of the reaction of isatin 50 with ethyl cyanoacetate. The reaction with ethanol ified with sulphuric acid afforded ethyl 3-cyano-2-oxo-1,2-dihydroquinoline-4-car ylate 114. Heating with a mixture of phosphorus oxychloride and phosphorus trichlo

The same synthetic protocol can be used for 95 by the transformation of it into oxime, 2-chloroquinoline-3-carbonitrile and then into 3-amino-1H-pyrazolo [3,4-b] quinoline, which is then modified in various ways to search for potential compounds of biological activity (Scheme 32-structures marked in blue) [79] . Section 2.5 discusses the few cases where isatin and pyrazolones are used in the Pfitzinger reaction for the synthesis of pyrazoloquinolines. Here, we have another one of the few cases that uses this compound, and specifically its derivative 113, which is formed as a result of the reaction of isatin 50 with ethyl cyanoacetate. The reaction with ethanol acidified with sulphuric acid afforded ethyl 3-cyano-2-oxo-1,2-dihydroquinoline-4-carboxylate 114.

Heating with a mixture of phosphorus oxychloride and phosphorus trichloride causes the introduction of the chlorine atom in the 2 position of the quinoline system, which results in the formation of compound 115. The last step is the reaction with hydrazine, which gives pyrazoloquinoline 116. This compound offers multiple possibilities for further functionalization and for obtaining a whole range of derivatives (e.g., by modifying the ester and amino groups, or by adding substituents to the nitrogen atom N1 (Scheme 33) [80] ). causes the introduction of the chlorine atom in the 2 position of the quinoline system, which results in the formation of compound 115. The last step is the reaction with hydrazine, which gives pyrazoloquinoline 116. This compound offers multiple possibilities for further functionalization and for obtaining a whole range of derivatives (e.g., by modifying the ester and amino groups, or by adding substituents to the nitrogen atom N1 (Scheme 33) [80] ).

Another substrate for the synthesis of pyrazolo [3,4-b] quinolines is 2-hydroxy-3acetylquinoline 118, which is easily prepared from ethyl acetoacetate 117 and o-aminoacetophenone/benzophenone 1 (Scheme 34). Arasakumar et al. applied 3-acetyl-4-phenylchinolin-2-one 118 and p-chlorophenylhydrazine for the synthesis of substituted 1H-pyrazolo[3,4-b]quinoline 120 [81] . Researchers have studied the effects of various Lewis acids (e.g., SnCl4, AlCl3, TiCl4, etc.), as well as of the microwave field, on the reaction yield. The best results were achieved with indium chloride (InCl3) Scheme 34. Syntheses of 1H-pyrazolo [3,4-b] quinolines from 2-hydroxy-3-acylquinolines.

Compound 118 can be subjected to the reaction with phosphorus trichloride (PCl3) to give 2-chloro-3-acetylquinolines 119, which is reacted with hydrazine. The product is 3,4-

Another substrate for the synthesis of pyrazolo [3,4-b] quinolines is 2-hydroxy-3-acetylquinoline 118, which is easily prepared from ethyl acetoacetate 117 and oaminoacetophenone/benzophenone 1 (Scheme 34). Arasakumar et al. applied 3-acetyl-4-phenyl-chinolin-2-one 118 and p-chlorophenylhydrazine for the synthesis of substituted 1H-pyrazolo[3,4-b]quinoline 120 [81] . Researchers have studied the effects of various Lewis acids (e.g., SnCl 4 , AlCl 3 , TiCl 4 , etc.), as well as of the microwave field, on the reaction yield. The best results were achieved with indium chloride (InCl 3 ). causes the introduction of the chlorine atom in the 2 position of the quinoline system, which results in the formation of compound 115. The last step is the reaction with hydrazine, which gives pyrazoloquinoline 116. This compound offers multiple possibilities for further functionalization and for obtaining a whole range of derivatives (e.g., by modifying the ester and amino groups, or by adding substituents to the nitrogen atom N1 (Scheme 33) [80] ).

Another substrate for the synthesis of pyrazolo [3,4-b] quinolines is 2-hydroxy-3acetylquinoline 118, which is easily prepared from ethyl acetoacetate 117 and o-aminoacetophenone/benzophenone 1 (Scheme 34). Arasakumar et al. applied 3-acetyl-4-phenylchinolin-2-one 118 and p-chlorophenylhydrazine for the synthesis of substituted 1H-pyrazolo[3,4-b]quinoline 120 [81] . Researchers have studied the effects of various Lewis acids (e.g., SnCl4, AlCl3, TiCl4, etc.), as well as of the microwave field, on the reaction yield. The best results were achieved with indium chloride (InCl3) Compound 118 can be subjected to the reaction with phosphorus trichloride (PCl 3 ) to give 2-chloro-3-acetylquinolines 119, which is reacted with hydrazine. The product is 3,4-disubstituted-1H-pyrazolo[3,4-b]quinoline 121 [82] . The free position in nitrogen N1 allows for numerous modifications of these compounds in terms of the biological properties [83] . 3-Acetyl-4-(methylthio)quinolin-2(1H)-one 124 is an example of another quinolin-2-one-based system that can be used both for the synthesis of pyrazoloquinolines and for other heterocycles as well [84] . It can be easily prepared from acetoacetanilide 122 by reacting with carbon disulfide in the presence of tetrabutylammonium bromide (TBAB), with the subsequent methylation yielding ketene dithioacetal 123. In the next step, the 123 is cyclised by boiling in o-dichlorobenzene. Reactions with hydrazine or phenylhydrazine in acetic acid lead to the formation of the corresponding pyrazoloquinolines 125. On the other hand, when DMF is used as a reaction medium instead, 125 angular pyrazolo[4,3c]quinolin-2-ones 126 are formed (Scheme 35) [85] . [82] . The free position in nitrogen N1 allows for numerous modifications of these compounds in terms of the biological properties [83] . 3-Acetyl-4-(methylthio)quinolin-2(1H)-one 124 is an example of another quinolin-2one-based system that can be used both for the synthesis of pyrazoloquinolines and for other heterocycles as well [84] . It can be easily prepared from acetoacetanilide 122 by reacting with carbon disulfide in the presence of tetrabutylammonium bromide (TBAB), with the subsequent methylation yielding ketene dithioacetal 123. In the next step, disubstituted-1H-pyrazolo[3,4-b]quinoline 121 [82] . The free position in nitrogen N1 allows for numerous modifications of these compounds in terms of the biological properties [83] . 3-Acetyl-4-(methylthio)quinolin-2(1H)-one 124 is an example of another quinolin-2one-based system that can be used both for the synthesis of pyrazoloquinolines and for other heterocycles as well [84] . It can be easily prepared from acetoacetanilide 122 by reacting with carbon disulfide in the presence of tetrabutylammonium bromide (TBAB), with the subsequent methylation yielding ketene dithioacetal 123. In the next step, The same procedure can be applied to aromatic amines or diamines and, as a result, other heterocyclic systems, such as phenanthrolines, can be obtained.

One of the oldest methods of pyrazoloquinolines synthesis are the two-component reactions of 5-arylamino pyrazoles and aromatic aldehydes ( Figure 10 ). The same procedure can be applied to aromatic amines or diamines and, as a result, other heterocyclic systems, such as phenanthrolines, can be obtained.

One of the oldest methods of pyrazoloquinolines synthesis are the two-component reactions of 5-arylamino pyrazoles and aromatic aldehydes ( Figure 10 ). In 1911, Michaelis heated 5-N-arylamino-1,3-disubstituted pyrazoles 132 with some aromatic aldehydes 133 in the presence of anhydrous ZnCl2 and obtained compounds to which he assigned a structure 134 (Scheme 37) [1] . He described them as yellow crystalline substances with a strong blue fluorescence in a toluene solution. Our group was interested in these types of compounds from the point of view of applying them to organic electroluminescent cells. The syntheses described by Michaelis were repeated, and the chemical structures of the compounds that were obtained were analysed by using 1 H NMR spectroscopy. It turned out that the structure of Michaelis 134 did not correspond to any of the compounds that he received, but that it did match the pyrazoloquinolines of 65 [87] . In 1911, Michaelis heated 5-N-arylamino-1,3-disubstituted pyrazoles 132 with some aromatic aldehydes 133 in the presence of anhydrous ZnCl 2 and obtained compounds to which he assigned a structure 134 (Scheme 37) [1] . He described them as yellow crystalline substances with a strong blue fluorescence in a toluene solution. Our group was interested in these types of compounds from the point of view of applying them to organic electroluminescent cells. The syntheses described by Michaelis were repeated, and the chemical structures of the compounds that were obtained were analysed by using 1 H NMR spectroscopy. It turned out that the structure of Michaelis 134 did not correspond to any of the compounds that he received, but that it did match the pyrazoloquinolines of 65 [87] . The same procedure can be applied to aromatic amines or diamines and, as a result, other heterocyclic systems, such as phenanthrolines, can be obtained.

One of the oldest methods of pyrazoloquinolines synthesis are the two-component reactions of 5-arylamino pyrazoles and aromatic aldehydes ( Figure 10 ). In 1911, Michaelis heated 5-N-arylamino-1,3-disubstituted pyrazoles 132 with some aromatic aldehydes 133 in the presence of anhydrous ZnCl2 and obtained compounds to which he assigned a structure 134 (Scheme 37) [1] . He described them as yellow crystalline substances with a strong blue fluorescence in a toluene solution. Our group was interested in these types of compounds from the point of view of applying them to organic electroluminescent cells. The syntheses described by Michaelis were repeated, and the chemical structures of the compounds that were obtained were analysed by using 1 H NMR spectroscopy. It turned out that the structure of Michaelis 134 did not correspond to any of the compounds that he received, but that it did match the pyrazoloquinolines of 65 [87] . be obtained from commercial 1,3-disubstituted 5-aminopyrazoles and the corresponding aryl halides by the procedures that are described by Buchwald [88] .

The next two-component procedure with N-arylpyrazoles is one of the oldest synthetic pyrazoloquinolines methods (Scheme 38). In 1936, Koćwa published a series of papers in which he obtained 2H-pyrazolo [3,4-b] quinolines 140 by reacting aryl isocyanates 137 or isothiocyanates 138 with N-arylpyrazoles 136 [3, 4] . By heating N-[5-methyl-1-phenyl-1,2dihydro-3H-pyrazol-3-ylidene]aniline 136 with phenyl isocyanate 137 at a temperature of 230-240 • C, product 140 is formed, while, in the case of phenyl isothiocyanate 138, intermediate 139 was isolated, which then cyclised to 140 by heating with PCl 5 at a temperature of 100-110 • C in 15 min (Scheme 38). obtained from commercial 1,3-disubstituted 5-aminopyrazoles and the corresponding aryl halides by the procedures that are described by Buchwald [88] . The next two-component procedure with N-arylpyrazoles is one of the oldest synthetic pyrazoloquinolines methods (Scheme 38). In 1936, Koćwa published a series of papers in which he obtained 2H-pyrazolo [3,4-b] quinolines 140 by reacting aryl isocyanates 137 or isothiocyanates 138 with N-arylpyrazoles 136 [3, 4] . By heating N- [5- For a long time, this was only one example of such reaction. It was not until 2021 that Kucharek and colleagues developed a one-step cyclisation reaction of 5-N-arylpyrazoles 132 in the presence of dimethylformamide diethyl acetal (DMF-DEA)/POCl3 at 80 °C. The yields of the obtained pyrazoloquinolines 59 ranged between 27 and 97% [90] .

We include in this part one more synthesis, in which the 5-N-arylamino derivatives of pyrazoles with the ester group in the 4 position of the pyrazole ring are obtained ( Figure  11 . Path 6b). obtained from commercial 1,3-disubstituted 5-aminopyrazoles and the corresponding aryl halides by the procedures that are described by Buchwald [88] . The next two-component procedure with N-arylpyrazoles is one of the oldest synthetic pyrazoloquinolines methods (Scheme 38). In 1936, Koćwa published a series of papers in which he obtained 2H-pyrazolo [3,4-b] quinolines 140 by reacting aryl isocyanates 137 or isothiocyanates 138 with N-arylpyrazoles 136 [3, 4] . By heating N- [5- For a long time, this was only one example of such reaction. It was not until 2021 that Kucharek and colleagues developed a one-step cyclisation reaction of 5-N-arylpyrazoles 132 in the presence of dimethylformamide diethyl acetal (DMF-DEA)/POCl3 at 80 °C. The yields of the obtained pyrazoloquinolines 59 ranged between 27 and 97% [90] .

We include in this part one more synthesis, in which the 5-N-arylamino derivatives of pyrazoles with the ester group in the 4 position of the pyrazole ring are obtained ( Figure  11 . Path 6b). For a long time, this was only one example of such reaction. It was not until 2021 that Kucharek and colleagues developed a one-step cyclisation reaction of 5-N-arylpyrazoles 132 in the presence of dimethylformamide diethyl acetal (DMF-DEA)/POCl 3 at 80 • C. The yields of the obtained pyrazoloquinolines 59 ranged between 27 and 97% [90] .

We include in this part one more synthesis, in which the 5-N-arylamino derivatives of pyrazoles with the ester group in the 4 position of the pyrazole ring are obtained ( Figure 11 . Path 6b).

This compound can be easily prepared in a one-pot reaction by starting from aniline 39, carbon disulfide, chloroacetic acid and hydrazine, which yields thiosemicarbazide 144. 132 in the presence of dimethylformamide diethyl acetal (DMF-DEA) yields of the obtained pyrazoloquinolines 59 ranged between 27 and We include in this part one more synthesis, in which the 5-N-ar of pyrazoles with the ester group in the 4 position of the pyrazole ring 11. Path 6b). 

Another one-component procedure is the synthesis which uses 4 arylidene substituted pyrazole derivatives ( Figure 12 ). Coutts and Edwards reacted o-nitrobenzaldehyde 148 and pyrazolone 10, which yielded 4-(2-nitrobenzylidene)-2-pyrazolin-5-ones 149 [94] . The next step was to use several methods of reductive cyclisation, such as cyclohexene/Pd(C), NaBH4 as well as zinc and acetic acid. The end product was 9-hydroxypyrazolo[3,4-b]quinolines 150a. After changing the reaction conditions as a result of reductive cyclisation, they obtained pyrazolo [3,4-b] quinoline 150b [95] (Scheme 41). The prereaction between o-nitrobenzaldehyde 148 and the corresponding pyrazolone 10 may be an alternative to avoid the synthesis of the anthranilic aldehyde 1 (R 3 = H, R 4 = H, halogen, OMe) that is needed for the Friedländer condensation (Scheme 3). 

Another one-component procedure is the synthesis which uses tuted pyrazole derivatives ( Figure 12 ). Coutts and Edwards reacted o-nitrobenzaldehyde 148 and py yielded 4-(2-nitrobenzylidene)-2-pyrazolin-5-ones 149 [94] . The next eral methods of reductive cyclisation, such as cyclohexene/Pd(C), Na and acetic acid. The end product was 9-hydroxypyrazolo [3,4-b] qu changing the reaction conditions as a result of reductive cyclisation, zolo [3,4-b] quinoline 150b [95] (Scheme 41). The prereaction between o 148 and the corresponding pyrazolone 10 may be an alternative to av the anthranilic aldehyde 1 (R 3 = H, R 4 = H, halogen, OMe) that is needed condensation (Scheme 3). Coutts and Edwards reacted o-nitrobenzaldehyde 148 and pyrazolone 10, which yielded 4-(2-nitrobenzylidene)-2-pyrazolin-5-ones 149 [94] . The next step was to use several methods of reductive cyclisation, such as cyclohexene/Pd(C), NaBH 4 as well as zinc and acetic acid. The end product was 9-hydroxypyrazolo[3,4-b]quinolines 150a. After changing the reaction conditions as a result of reductive cyclisation, they obtained pyrazolo [3,4b] quinoline 150b [95] (Scheme 41). The prereaction between o-nitrobenzaldehyde 148 and the corresponding pyrazolone 10 may be an alternative to avoid the synthesis of the anthranilic aldehyde 1 (R 3 = H, R 4 = H, halogen, OMe) that is needed for the Friedländer condensation (Scheme 3).

As part of the research on nitrenes, Kametani and colleagues performed reductive cyclisation reactions on 4-(4,5-methylenedioxy-2-nitrobenzylidene)-2-phenyloxazolones by using triethyl phosphite (P(OEt) 3 ). These compounds were prepared from 4,5-dimethoxy-2-nitrobenzaldehyde (145; R 3,4 = OMe) and N-benzoylglycine. The reaction resulted in the formation of 2-phenyloxazolo [5,4-b] quinoline [96] . Nishiwaki also tried to cyclise 4-(2-nitrobenzylidene)-2-pyrazolin-5-ones 149 by using P(OEt) 3 as the reducing agent. However, instead of the expected pyrazoloquinolines, a whole range of other products were isolated from the reaction mixture, the structures (e.g., 151, 152, 153) of which are shown in Scheme 41 [97] . Tomasik and Danel used reductive cyclisation with iron powder and glacial acetic acid to synthesise pyrazoloquinolines 150 from o-nitrobenzylidene derivatives 149, however with moderate yields [98] . As part of the research on nitrenes, Kametani and colleagues performed reductive cyclisation reactions on 4-(4,5-methylenedioxy-2-nitrobenzylidene)-2-phenyloxazolones by using triethyl phosphite (P(OEt)3). These compounds were prepared from 4,5-dimethoxy-2-nitrobenzaldehyde (145; R 3,4 = OMe) and N-benzoylglycine. The reaction resulted in the formation of 2-phenyloxazolo [5,4-b] quinoline [96] . Nishiwaki also tried to cyclise 4-(2-nitrobenzylidene)-2-pyrazolin-5-ones 149 by using P(OEt)3 as the reducing agent. However, instead of the expected pyrazoloquinolines, a whole range of other products were isolated from the reaction mixture, the structures (e.g., 151, 152, 153) of which are shown in Scheme 41 [97] . Tomasik and Danel used reductive cyclisation with iron powder and glacial acetic acid to synthesise pyrazoloquinolines 150 from o-nitrobenzylidene derivatives 149, however with moderate yields [98] .

In concluding the discussion of the use of single-component systems, one could mention the work of DeWald on the metabolites of Zolazepam 154 (R 1 = Me). After the administration of Zolazepam to rats, the metabolite 154a (R 1 = H) was found in their urine. In order to synthesise it, the Zolazepam was demethylated with boiling pyridine hydrochloride; however, the reaction was unsuccessful, and instead of 154a, 155a was obtained (R 2 = Me, R 1 = H). Compound 156 was synthesised to obtain an isomer 155b (R 2 = H, R 1 = Me) (Scheme 42) [99] . In concluding the discussion of the use of single-component systems, one could mention the work of DeWald on the metabolites of Zolazepam 154 (R 1 = Me). After the administration of Zolazepam to rats, the metabolite 154a (R 1 = H) was found in their urine. In order to synthesise it, the Zolazepam was demethylated with boiling pyridine hydrochloride; however, the reaction was unsuccessful, and instead of 154a, 155a was obtained (R 2 = Me, R 1 = H). Compound 156 was synthesised to obtain an isomer 155b (R 2 = H, R 1 = Me) (Scheme 42) [99] .

To sum up, the synthesis of pyrazoloquinolines with the use of a single-component system (e.g., 148) is of no practical importance in the light of other, much more efficient methods. To sum up, the synthesis of pyrazoloquinolines with the use of a single-component system (e.g., 148) is of no practical importance in the light of other, much more efficient methods.

In recent years, the significant development of multicomponent reactions in organic chemistry has been observed, including the syntheses of heterocyclic compounds [100, 101] . Many review publications and monographs on this issue have been published [102, 103] . As far as pyrazoloquinolines are concerned, the multicomponent reactions described so far in the literature are limited to the two methodologies presented below (Figure 13 ). 

In recent years, the significant development of multicomponent reactions in organic chemistry has been observed, including the syntheses of heterocyclic compounds [100, 101] . Many review publications and monographs on this issue have been published [102, 103] . As far as pyrazoloquinolines are concerned, the multicomponent reactions described so far in the literature are limited to the two methodologies presented below ( Figure 13 ).

To sum up, the synthesis of pyrazoloquinolines with the use of a single-component system (e.g., 148) is of no practical importance in the light of other, much more efficient methods.

In recent years, the significant development of multicomponent reactions in organic chemistry has been observed, including the syntheses of heterocyclic compounds [100, 101] . Many review publications and monographs on this issue have been published [102, 103] . As far as pyrazoloquinolines are concerned, the multicomponent reactions described so far in the literature are limited to the two methodologies presented below (Figure 13 ). Nogueras et al. investigated the mechanism of the abovementioned reaction. After carrying out a few experiments, they came to the conclusion that the first step is the Knovenagel condensation between dimedone 157 and aldehyde 133, and then, in the Michael addition, there is the attachment of aminopyrazole 17 with the subsequent cyclocondensation between the dimedone carbonyl group and the pyrazole amino group [105] . This reaction has been modified many times in terms of different reaction conditions. These modifications include conducting reactions in the microwave field, with or without a catalyst such as L-proline [106, 107] . One of the important synthetic aspects of green chemistry is the use of ultrasound in organic synthesis. This approach was used by Maddila and colleagues for the synthesis of pyrazoloquinolines. The reactions took several minutes, and the yields of the products that were obtained were relatively high (in the order of 70-98%) [108] . Other modifications to this reaction consisted of the use of various catalysts, such as H 3 PW 12 O 14 or nanomagnetic celulose in ionic liquids [109, 110] . In all mentioned cases, when dimedone 157 was used, the central heterocyclic ring was hydrogenated. In some cases, a fully aromatic ring was produced (Scheme 43). Thus, Shi and Wang used sodium 1-dodecanesulfonate SDS as a catalyst in the aqueous reaction medium for the same components (17, 133 and 157) [111] . The end product was a system with a fully aromatic pyridine fragment 161. The authors mentioned in the paper that the mechanism of this reaction is not fully understood, and especially how the hydrogen molecule is lost from the structure. The same reaction that was carried out in polyethylene glycol PEG-400 yielded the same product with an aromatic pyridine fragment [112] . Nogueras et al. investigated the mechanism of the abovementioned reaction. After carrying out a few experiments, they came to the conclusion that the first step is the Knovenagel condensation between dimedone 157 and aldehyde 133, and then, in the Michael addition, there is the attachment of aminopyrazole 17 with the subsequent cyclocondensation between the dimedone carbonyl group and the pyrazole amino group [105] . This reaction has been modified many times in terms of different reaction conditions. These modifications include conducting reactions in the microwave field, with or without a catalyst such as L-proline [106, 107] . One of the important synthetic aspects of green chemistry is the use of ultrasound in organic synthesis. This approach was used by Maddila and colleagues for the synthesis of pyrazoloquinolines. The reactions took several minutes, and the yields of the products that were obtained were relatively high (in the order of 70-98%) [108] . Other modifications to this reaction consisted of the use of various catalysts, such as H3PW12O14 or nanomagnetic celulose in ionic liquids [109, 110] . In all The final compounds 65 are obtained by heating a mixture of aromatic amine 39, aromatic aldehyde 133 and pyrazolone 10 in ethylene glycol for two hours. After cooling and digestion with methanol/ethanol, the pyrazoloquinolines precipitate as a crystalline solid. The yields of the reactions are in the range of 20-33%, although some authors have claimed that they obtained pyrazoloquinolines 65 in the order of 50-60% by this method [114] . Aromatic amines 39 can contain both electron-donating groups and electronwithdrawing groups in the o, m, or para positions. Aromatic aldehydes 133 can include various benzaldehyde derivatives, as well as naphtalene-1/2-carbaldehyde, but it is unable to obtain derivatives of 9-formylanthracene. Despite moderate yields, it seems to be the best method of obtaining 4 substituted aryl pyrazoloquinolines, which successfully replaces the Friedländer synthesis by using substituted o-aminobenzophenones. Hedge and Shetty describe a multicomponent synthesis of 1,4-diphenyl-3-methyl-4,9-dihydro-1Hpyrazolo [3,4-b] quinolines 135 that used L-proline as the catalyst (Scheme 44) [115] . The components were the same as in Tomasik et al.'s procedure, but the final product was not aromatised in the final step (Path 8b; C4-C4a, N9-C9a, C4-C3a). mentioned cases, when dimedone 157 was used, the central heterocyclic ring was hydrogenated. In some cases, a fully aromatic ring was produced (Scheme 43). Thus, Shi and Wang used sodium 1-dodecanesulfonate SDS as a catalyst in the aqueous reaction medium for the same components (17, 133 and 157 ) [111] . The end product was a system with a fully aromatic pyridine fragment 161. The authors mentioned in the paper that the mechanism of this reaction is not fully understood, and especially how the hydrogen molecule is lost from the structure. The same reaction that was carried out in polyethylene glycol PEG-400 yielded the same product with an aromatic pyridine fragment [112] .

Contrary to the previously described multicomponent reactions (Path 8a; The final compounds 65 are obtained by heating a mixture of aromatic amine 39, aromatic aldehyde 133 and pyrazolone 10 in ethylene glycol for two hours. After cooling and digestion with methanol/ethanol, the pyrazoloquinolines precipitate as a crystalline solid. The yields of the reactions are in the range of 20-33%, although some authors have claimed that they obtained pyrazoloquinolines 65 in the order of 50-60% by this method [114] . Aromatic amines 39 can contain both electron-donating groups and electron-withdrawing groups in the o, m, or para positions. Aromatic aldehydes 133 can include various benzaldehyde derivatives, as well as naphtalene-1/2-carbaldehyde, but it is unable to obtain derivatives of 9-formylanthracene. Despite moderate yields, it seems to be the best method of obtaining 4 substituted aryl pyrazoloquinolines, which successfully replaces the Friedländer synthesis by using substituted o-aminobenzophenones. Hedge and Shetty describe a multicomponent synthesis of 1,4-diphenyl-3-methyl-4,9-dihydro-1H-pyrazolo [3,4-b] quinolines 135 that used L-proline as the catalyst (Scheme 44) [115] . The In the next stage, the authors subjected the obtained systems (164 and 165) to reactions with 1,2-diaminobenzene in order to obtain the quinoxaline derivatives 166. All the steps that are described were carried out under microwave irradiation.

The reaction that was performed by Rajesh et al. is described as a "sequential fourcomponent reaction", which makes it a kind of record holder among the multicomponent reactions that are used for the synthesis of pyrazoloquinolines 165. They reacted 3-aminocrotononitrile and phenylhydrazine with an addition of L-proline for 10 min in boiling water, and they then added an equimolar mixture of aldehyde 138 and dione 163. The whole mixture was then heated for 1-1.5 h [117] . Quiroga [118] . When they used 86 (X = NH), the middle heterocyclic ring was unsaturated. The formation of the linear benzo[g]pyrazolo[3,4b]quinoline system was not observed. The resulting compounds were screened against some Mycobacterium strains. components were the same as in Tomasik et al.'s procedure, but the final product was not aromatised in the final step (Path 8b; C4-C4a, N9-C9a, C4-C3a).

Another group of multicomponent reactions are those that use 2-hydroxynaphtalene-1,4-dione 163. Li et al. synthesised two series of compounds: benzo[h]isoxazolo [5,4-b] quinolines 164 from 5-amino-3-methyloxazole 162, and benzo[h]pyrazolo [3,4-b] In the next stage, the authors subjected the obtained systems (164 and 165) to reactions with 1,2-diaminobenzene in order to obtain the quinoxaline derivatives 166. All the steps that are described were carried out under microwave irradiation.

The reaction that was performed by Rajesh et al. is described as a "sequential fourcomponent reaction", which makes it a kind of record holder among the multicomponent reactions that are used for the synthesis of pyrazoloquinolines 165. They reacted 3-aminocrotononitrile and phenylhydrazine with an addition of L-proline for 10 min in boiling water, and they then added an equimolar mixture of aldehyde 138 and dione 163. The whole mixture was then heated for 1-1. Another multicomponent reaction for the synthesis of pyrazoloquinoline derivatives 170 differs from the others by the procedure in which ingredients such as aminopyrazole 86, 2-hydroxy-1,4-napthalenedione 163 and cinnamaldehyde 169 are ground in a mortar with a little addition of water. The authors call it, "liquid assisted grinding or LAG." After grinding is completed, the product is simply recrystallised from an appropriate solvent (Scheme 46) [120] . Another multicomponent reaction for the synthesis of pyrazoloquinoline derivatives 170 differs from the others by the procedure in which ingredients such as aminopyrazole 86, 2-hydroxy-1,4-napthalenedione 163 and cinnamaldehyde 169 are ground in a mortar with a little addition of water. The authors call it, "liquid assisted grinding or LAG." After grinding is completed, the product is simply recrystallised from an appropriate solvent (Scheme 46) [120] .

The multicomponent reactions with the use of 163 that have been described so far led to the preparation of angular benzo[g]pyrazolo [3,4-b] quinolin-5,6-diones (e. g., 165, 168 or  169) . It is also possible to obtain a linear system of the mentioned heterocyclic system.

Gutierez Indium chloride (InCl3), as a catalyst, was also used in the three-component reaction to synthesise not only pyrazoloquinolines, but also pyrimidine derivatives. Instead of formaldehyde, the authors used a number of aromatic aldehydes. In the case of 1,3-cyclohexanedione, a product with a hydrogenated pyridine ring was obtained, and, in the case of 1,3-pentanedione, indane-1,3-dione and naphthalene-2-hydroxy-1,4-dione, which are products with aromatic pyridine fragments, were obtained [122] . Wu et al., as a catalyst, used a 10-15 mol% amount of (NH4)2HPO4 for 2-hydroxynaphthalene-1,4-dione 163, aromatic aldehyde 133 and 5-amino-3-methyl-1-phenylpyrazole 86 three-component reactions [123] . The isolated yields of the benzo[h]pyrazolo [3,4-b] quinolines ranged from 80-95%.

Due to the concern for the protection of the natural environment, we have observed an increasing tendency to change the approach to organic synthesis. This is manifested, inter alia, by the use of water as the reaction medium, or by the use of ionic liquids. One such example is PEG1000-based dicationic acid ionic liquid, which has been used by Ren Indium chloride (InCl 3 ), as a catalyst, was also used in the three-component reaction to synthesise not only pyrazoloquinolines, but also pyrimidine derivatives. Instead of formaldehyde, the authors used a number of aromatic aldehydes. In the case of 1,3-cyclohexanedione, a product with a hydrogenated pyridine ring was obtained, and, in the case of 1,3-pentanedione, indane-1,3-dione and naphthalene-2-hydroxy-1,4-dione, which are products with aromatic pyridine fragments, were obtained [122] . Wu et al., as a catalyst, used a 10-15 mol% amount of (NH 4 ) 2 HPO 4 for 2-hydroxynaphthalene-1,4-dione 163, aromatic aldehyde 133 and 5-amino-3-methyl-1-phenylpyrazole 86 threecomponent reactions [123] . The isolated yields of the benzo[h]pyrazolo [3,4-b] quinolines ranged from 80-95%.

Due to the concern for the protection of the natural environment, we have observed an increasing tendency to change the approach to organic synthesis. This is manifested, inter alia, by the use of water as the reaction medium, or by the use of ionic liquids. One such example is PEG 1000 -based dicationic acid ionic liquid, which has been used by Ren L-proline is a frequently used catalyst in multicomponent reactions. Karamthulla et al. used it in the synthesis of linear 2H-benzo[g]pyrazolo [3,4-b] quinolone-5,10(4H,11H)-dione derivatives [125] . The reaction that was performed differed slightly in terms of the choice of components, and, namely, by the fact that 3-amino-5-methylpyrazole was used instead of the 1-phenyl-3-methyl-5-aminopyrazole 86. Contrary to the reactions that are shown in Scheme 47, no aromatisation of the pyridine ring was observed.

In multicomponent reactions where pyrazoloquinolines are synthesised, isatin is sometimes used. We mentioned it in the context of the Pfitzinger reaction that was described earlier. In this case, isatin made a significant contribution to the construction of the pyrazoloquinolines skeleton (Scheme 17 Dabiri conducted the abovementioned reaction in the presence of L-proline (10 mol%) in boiling water for 6-7.5 h. The researchers additionally conducted additional studies by replacing isatin with acenaphtylen-1,2-dione. The yields of the corresponding spiro derivatives were in the range of 50-70% [127] . Spiro compounds based on pyrazoloquinolines (i.e., spiro[indoline-3,4'-pyrazolo [3,4-b] quinoline]-2.5'(6'H) dione) can also be obtained without any catalysts, as was proven by Rong and his colleagues by heating isatin 50, dimedone 157 (or 1,3-cyclohexanedione 43) and 3-amino-1H-pyrazole in water or dilute acetic acid [128] . This reaction meets 100% of the requirements of the so-called "green chemistry".

The catalysts that have been discussed so far in multicomponent reactions were of a homogeneous nature. Baradani and colleagues used Fe3O4@Cu(OH)x as a catalyst in the three-component reaction of dimedone 173, aminopyrazole 86 and 5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinoline-1,2-dione, instead of isatin [129] . The reactions were carried out in the environment of water/ethanol with the addition of a nanocatalyst, and they lasted from 8 to 9 h. After the reaction was completed, the catalyst was removed with a strong magnet. The final product was separated and purified with chromatographic techniques.

In the literature, you can find descriptions of three-comonent reactions that use β- Dabiri conducted the abovementioned reaction in the presence of L-proline (10 mol%) in boiling water for 6-7.5 h. The researchers additionally conducted additional studies by replacing isatin with acenaphtylen-1,2-dione. The yields of the corresponding spiro derivatives were in the range of 50-70% [127] . Spiro compounds based on pyrazoloquinolines (i.e., spiro[indoline-3,4'-pyrazolo [3,4-b] quinoline]-2.5'(6'H) dione) can also be obtained without any catalysts, as was proven by Rong and his colleagues by heating isatin 50, dimedone 157 (or 1,3-cyclohexanedione 43) and 3-amino-1H-pyrazole in water or dilute acetic acid [128] . This reaction meets 100% of the requirements of the so-called "green chemistry".

The catalysts that have been discussed so far in multicomponent reactions were of a homogeneous nature. Baradani and colleagues used Fe 3 O 4 @Cu(OH)x as a catalyst in the three-component reaction of dimedone 173, aminopyrazole 86 and 5,6-dihydro-4Hpyrrolo[3,2,1-ij]quinoline-1,2-dione, instead of isatin [129] . The reactions were carried out in the environment of water/ethanol with the addition of a nanocatalyst, and they lasted from 8 to 9 h. After the reaction was completed, the catalyst was removed with a strong magnet. The final product was separated and purified with chromatographic techniques.

In the literature, you can find descriptions of three-comonent reactions that use β-tetralone 175 or α-teralone 177 for the synthesis of angular benzo[f ]-197 or benzo[g] pyrazoloquinolines 200. The reactions were carried out by melting the reagents [130] . The first of the abovementioned reactions ran smoothly and produced the expected benzo[f ] derivative 176 (Scheme 49). from 8 to 9 h. After the reaction was completed, the catalyst was removed with a strong magnet. The final product was separated and purified with chromatographic techniques.

In the literature, you can find descriptions of three-comonent reactions that use βtetralone 175 or α-teralone 177 for the synthesis of angular benzo[f]-197 or benzo[g] pyrazoloquinolines 200. The reactions were carried out by melting the reagents [130] . The first of the abovementioned reactions ran smoothly and produced the expected benzo Quiroga and co-workers tried to repeat the earlier procedure to obtain the benzo[h]isomer 179, and unfortunately, in this case, they were not successful. The main product turned out to be bis-pyrazolo[3,4-b;3',4'-e]pyridine 180. Therefore, they changed the procedure and first synthesised a 2-arylidene derivative of α-tetralone 178, which was then reacted with aminopyrazole 17 by melting. This time, a derivative 179 was obtained (Scheme 50). Quiroga and co-workers tried to repeat the earlier procedure to obtain the benzo[h]isomer 179, and unfortunately, in this case, they were not successful. The main product turned out to be bis-pyrazolo [3,4-b;3',4 '-e]pyridine 180. Therefore, they changed the procedure and first synthesised a 2-arylidene derivative of α-tetralone 178, which was then reacted with aminopyrazole 17 by melting. This time, a derivative 179 was obtained (Scheme 50). [131] . The reaction also proceeded with cyclohexanone and cyclopentanone, but it failed with α-tetralone and 2-hydroxynaphtalene-1,4-dione 163.

The resulting compounds exhibited intense emission properties in solution, and in the solid state as well. Moreover, when the R 3 was NMe2, the compound exhibited aggregation-induced emission AIE. To conclude our review of the most important pyrazoloquinoline reactions in the last 100 years, we were very pleased with the work that was published by Tiwari et al. in 2021 [132] . It is a very universal method that allows one to obtain a whole range of pyrazoloquinolines 59 from commercial ingredients, such as aromatic amines 39, pyrazolones 10 and dimethylsulfoxide 181. The reaction proceeds in the presence of trifluoacetic anhydride TFA. The authors proposed the mechanism of this reaction, where one of the intermediate steps is the azadiene system 182, which is annulated and then aromatised to produce the final pyrazolo [ [131] . The reaction also proceeded with cyclohexanone and cyclopentanone, but it failed with α-tetralone and 2-hydroxynaphtalene-1,4-dione 163. The resulting compounds exhibited intense emission properties in solution, and in the solid state as well. Moreover, when the R 3 was NMe 2 , the compound exhibited aggregationinduced emission AIE. To conclude our review of the most important pyrazoloquinoline reactions in the last 100 years, we were very pleased with the work that was published by Tiwari et al. in 2021 [132] . It is a very universal method that allows one to obtain a whole range of pyrazoloquinolines 59 from commercial ingredients, such as aromatic amines Perhaps this reaction will be an alternative to the procedure that was developed by Brack in 1965 (Scheme 19), which allows the obtainment of all of the possible combinations of the substituents for 10 (R 1 , R 2 = H, Me, Ph) in the pyrazole ring. Tiwari et al. employed only two pyrazolone derivatives 10 (R 1 = Ph, R 2 = Me and R 1,2 = Ph). Finally, it may be mentioned that the authors expected a completely different result; thus, this is an example of serendipity in organic chemistry.

In view of the ever-growing demand for many high-tech and biomedical applications, the group of 1H-pyrazolo [3,4-b] quinolines has gained considerable interest from the scientific community, which is mainly due to their intrinsic optical and photophysical characteristics. Over the past decades, many researchers have made some efforts to understand the relationship between the structure and the optical properties of these compounds. However, even though the establishment of the structure obtained by Niementowski was made in 1928 [2] , it was only in the late 1990s and mid 2000s that a number of reports related to the spectroscopic characteristics and the computational analysis of 1H-pyrazolo[3,4-b]quinoline derivatives (see Figure 1 in the Introduction) were published [133] [134] [135] [136] [137] [138] .

Structurally, pyrazoloquinolines are the products of the ring fusion of the heteroaromatic pyrazole and quinoline moieties, which gives rise to a rigid D-π-A system ( Figure  14) . Separately, these building blocks play a crucial role in the design of many functional materials. For instance, quinoline scaffolds are frequently used as electron-accepting components in light-harvesting systems [139, 140] , or as optical limiters [141] . Furthermore, quinoline-based molecules exhibit highly efficient electron-transporting properties that are combined with thermal and redox robustness and high photoluminescence quantum yields. These features are of paramount importance in the construction of many high-tech devices, such as organic optoelectronics (OLEDs) [142, 143] , photodiode detectors [144] and photovoltaic cells (OPVs) [145] . On the other hand, the pyrazole unit often acts as an electron donor in chromophore systems, which is due to the presence of two electron-rich adjacent nitrogen atoms [146, 147] . Especially in conjunction with various electron acceptors (e.g., electron-deficient aromatics and heteroaromatics), pyrazole derivatives emerge as highly efficient, tunable light emitters [148] [149] [150] . Such structural motifs, including pyrazoloquinolines, have been intensively studied in the area of advanced dye chemistry, Perhaps this reaction will be an alternative to the procedure that was developed by Brack in 1965 (Scheme 19) , which allows the obtainment of all of the possible combinations of the substituents for 10 (R 1 , R 2 = H, Me, Ph) in the pyrazole ring. Tiwari et al. employed only two pyrazolone derivatives 10 (R 1 = Ph, R 2 = Me and R 1,2 = Ph). Finally, it may be mentioned that the authors expected a completely different result; thus, this is an example of serendipity in organic chemistry.

In view of the ever-growing demand for many high-tech and biomedical applications, the group of 1H-pyrazolo [3,4-b] quinolines has gained considerable interest from the scientific community, which is mainly due to their intrinsic optical and photophysical characteristics. Over the past decades, many researchers have made some efforts to understand the relationship between the structure and the optical properties of these compounds. However, even though the establishment of the structure obtained by Niementowski was made in 1928 [2] , it was only in the late 1990s and mid 2000s that a number of reports related to the spectroscopic characteristics and the computational analysis of 1H-pyrazolo[3,4-b]quinoline derivatives (see Figure 1 in the Introduction) were published [133] [134] [135] [136] [137] [138] .

Structurally, pyrazoloquinolines are the products of the ring fusion of the heteroaromatic pyrazole and quinoline moieties, which gives rise to a rigid D-π-A system ( Figure 14) . Separately, these building blocks play a crucial role in the design of many functional materials. For instance, quinoline scaffolds are frequently used as electron-accepting components in light-harvesting systems [139, 140] , or as optical limiters [141] . Furthermore, quinolinebased molecules exhibit highly efficient electron-transporting properties that are combined with thermal and redox robustness and high photoluminescence quantum yields. These features are of paramount importance in the construction of many high-tech devices, such as organic optoelectronics (OLEDs) [142, 143] , photodiode detectors [144] and photovoltaic cells (OPVs) [145] . On the other hand, the pyrazole unit often acts as an electron donor in chromophore systems, which is due to the presence of two electron-rich adjacent nitrogen atoms [146, 147] . Especially in conjunction with various electron acceptors (e.g., electron-deficient aromatics and heteroaromatics), pyrazole derivatives emerge as highly efficient, tunable light emitters [148] [149] [150] . Such structural motifs, including pyrazoloquinolines, have been intensively studied in the area of advanced dye chemistry, and most recently as electroluminescent materials [6, 151, 152] , fluorescence sensors [153, 154] and second-order nonlinear optical materials [155] [156] [157] . and most recently as electroluminescent materials [6, 151, 152] , fluorescence sensors [153, 154] and second-order nonlinear optical materials [155] [156] [157] . Generally, the absorption spectra of 1H-pyrazolo[3,4-b]quinolines contain two absorption bands in the UV-Vis region of light: I) The broad S0→S1 (π→π*) transition with an absorption maxima that ranges from ca. 380 to 420 nm; and II) More or less pronounced (depending on the substitution pattern) multiple bands at shorter wavelengths (<300 nm), which can be attributed to S0→Sn (mixed π→π* and n→π*) transitions. Furthermore, it can be observed that, in the case of pyrazoloquinolines substituted with donor and/or acceptor groups, the long-wavelength absorption maxima are slightly redshifted, corresponding to their unsubstituted analogues [47, 158, 159] . In fact, light-induced transitions in D-π-A chromophores are directed from an electron-rich to an electron-deficient unit, which results in a significant charge separation within the excited state (see Figure 14 ) [160] . In most cases, such a charge separation leads to the formation of conformationally disrupted and poorly emissive intramolecular charge transfer (ICT) states. However, the rigidity of the pyrazoloquinoline skeleton promotes electronically allowed emission, as the frontier orbitals that participate in the 1 CT→S0 transition have parallel orientation and are, therefore, markedly overlapped [161] . Subsequently, 1H-pyrazolo [3,4-b] quinolines are highly fluorescent in the blue or greenish-blue parts of the spectrum, with quantum fluorescence yields reaching unity in some cases ( Figure 15 ) [20, 158, 162] . Generally, the absorption spectra of 1H-pyrazolo[3,4-b]quinolines contain two absorption bands in the UV-Vis region of light: I) The broad S 0 →S 1 (π→π*) transition with an absorption maxima that ranges from ca. 380 to 420 nm; and II) More or less pronounced (depending on the substitution pattern) multiple bands at shorter wavelengths (<300 nm), which can be attributed to S 0 →S n (mixed π→π* and n→π*) transitions. Furthermore, it can be observed that, in the case of pyrazoloquinolines substituted with donor and/or acceptor groups, the long-wavelength absorption maxima are slightly redshifted, corresponding to their unsubstituted analogues [47, 158, 159] . In fact, light-induced transitions in D-π-A chromophores are directed from an electron-rich to an electron-deficient unit, which results in a significant charge separation within the excited state (see Figure 14 ) [160] . In most cases, such a charge separation leads to the formation of conformationally disrupted and poorly emissive intramolecular charge transfer (ICT) states. However, the rigidity of the pyrazoloquinoline skeleton promotes electronically allowed emission, as the frontier orbitals that participate in the 1 CT→S 0 transition have parallel orientation and are, therefore, markedly overlapped [161] . Subsequently, 1H-pyrazolo [3,4-b] quinolines are highly fluorescent in the blue or greenish-blue parts of the spectrum, with quantum fluorescence yields reaching unity in some cases ( Figure 15 ) [20, 158, 162] . Molecules 2022, 27, x FOR PEER REVIEW 39 of 67 . Figure 15 . Structures and photophysical properties of differently substituted 1H-pyrazolo [3,4b] quinolines. The data presented were measured in chloroform [158] .

A tremendous variety of synthetic approaches has led to an extension of the portfolio of pyrazoloquinolines with tunable luminescence features. Exemplarily, an introduction of additional electron-donating and electron-withdrawing groups within the chromophore results in the formation of spatially extended dipolar (or quadrupolar) systems. A considerable charge separation within the electronically excited states of these molecules results in a redshift of the emission bands, which noticeably proceeds with an increase in the solvent polarity [138, 159, 163] . However, the fluorescence intensity of such organic dyes decreases at the same time, which is due to an enhancement of the rate of nonradiative decay via intramolecular rotations within excited ICT states [164, 165] . Another significant process that leads to the rapid deactivation of excited states is referred to as "photoinduced electron transfer (PET)" [166] [167] [168] [169] . In this case, an electron donor (e.g., dialkylamine group) and the luminophore are commonly separated by a short alkyl spacer, which electronically disconnects the π-conjugation between the receptor and the electron donor units. The excitation of such a system is followed by the PET process, which leads to an immediate nonradiative decay to the ground state. However, most of the pyrazoloquinolines that are substituted with dialkyl and diaryl amines are deliberately designed for the in-active interruption of the aforementioned fluorescence-quenching mechanisms, which makes them promising "turn-on" sensors.

Since the electroluminescence properties of 1H-pyrazolo[3,4-b]quinolines have been frequently reported for many years [20, 47, [170] [171] [172] [173] [174] , in this review, we focus on their use as efficient fluorescence probes. The operation of many fluorescent indicators is based on a noticeable enhancement of the fluorescence emission upon the addition of metal cations to the fluorescing medium. Exemplarily, in 2002, Rurack et al. reported the synthesis of two aza-crown-modified 1,3-diphenyl-pyrazoloquinolines that exhibited high fluorometric sensitivity to Na + and Ca 2+ cations (see Figure 16a ) [5] . The main concept of this study relied upon the structural connection between the nitrogen lone pair of the analyte receptor and the chromophore system, either by a σ-spacer (compound PQ 1) or by a perpendicular π-conjugated arrangement (compound PQ 2). Derivative PQ 1 proved to be A tremendous variety of synthetic approaches has led to an extension of the portfolio of pyrazoloquinolines with tunable luminescence features. Exemplarily, an introduction of additional electron-donating and electron-withdrawing groups within the chromophore results in the formation of spatially extended dipolar (or quadrupolar) systems. A considerable charge separation within the electronically excited states of these molecules results in a redshift of the emission bands, which noticeably proceeds with an increase in the solvent polarity [138, 159, 163] . However, the fluorescence intensity of such organic dyes decreases at the same time, which is due to an enhancement of the rate of nonradiative decay via intramolecular rotations within excited ICT states [164, 165] . Another significant process that leads to the rapid deactivation of excited states is referred to as "photoinduced electron transfer (PET)" [166] [167] [168] [169] . In this case, an electron donor (e.g., dialkylamine group) and the luminophore are commonly separated by a short alkyl spacer, which electronically disconnects the π-conjugation between the receptor and the electron donor units. The excitation of such a system is followed by the PET process, which leads to an immediate nonradiative decay to the ground state. However, most of the pyrazoloquinolines that are substituted with dialkyl and diaryl amines are deliberately designed for the in-active interruption of the aforementioned fluorescence-quenching mechanisms, which makes them promising "turn-on" sensors.

Since the electroluminescence properties of 1H-pyrazolo[3,4-b]quinolines have been frequently reported for many years [20, 47, [170] [171] [172] [173] [174] , in this review, we focus on their use as efficient fluorescence probes. The operation of many fluorescent indicators is based on a noticeable enhancement of the fluorescence emission upon the addition of metal cations to the fluorescing medium. Exemplarily, in 2002, Rurack et al. reported the synthesis of two aza-crown-modified 1,3-diphenyl-pyrazoloquinolines that exhibited high fluorometric sensitivity to Na + and Ca 2+ cations (see Figure 16a ) [5] . The main concept of this study relied upon the structural connection between the nitrogen lone pair of the analyte receptor and the chromophore system, either by a σ-spacer (compound PQ 1) or by a perpendicular π-conjugated arrangement (compound PQ 2). Derivative PQ 1 proved to be weakly emissive in polar solvents (Φ f = 0.02 in acetonitrile, compared to Φ f = 0.54 in hexane), which was mainly due to the PET-fluorescence-quenching mechanism. On the contrary, pyrazoloquinoline PQ 2 showed an intense dual emission from LE and ICT fluorescent species (Φ f = 0.18 in acetonitrile, compared to Φ f = 0.37 in hexane). Furthermore, both derivatives showed highly desirable effects in the presence of analyte species (i.e., metal ions) on the basis of two different sensing mechanisms. The authors demonstrated that dye PQ 1 readily bound monovalent Na + and bivalent Ca 2+ cations, with a concomitant increase in the fluorescence intensity. These observations were in unambiguous agreement with a proposed PET-signalling mechanism. More interestingly, pyrazoloquinoline PQ 2 performed as a dual emissive sensor with a high fluorescence output for both states of the detection system: bound and unbound. In this case, the presence of bivalent Ca 2+ cations alternated the nature of the excited state of the fluorophore from the low-lying ICT state to the blue-shifted LE state, with a significant enhancement in the emission (from Φ f = 0.18 to Φ f = 0.35 in acetonitrile) at the same time. In contrast, the addition of Na + ions to PQ 2 did not change its spectral characteristics markedly. weakly emissive in polar solvents (Φf = 0.02 in acetonitrile, compared to Φf = 0.54 in hexane), which was mainly due to the PET-fluorescence-quenching mechanism. On the contrary, pyrazoloquinoline PQ 2 showed an intense dual emission from LE and ICT fluorescent species (Φf = 0.18 in acetonitrile, compared to Φf = 0.37 in hexane). Furthermore, both derivatives showed highly desirable effects in the presence of analyte species (i.e., metal ions) on the basis of two different sensing mechanisms. The authors demonstrated that dye PQ 1 readily bound monovalent Na + and bivalent Ca 2+ cations, with a concomitant increase in the fluorescence intensity. These observations were in unambiguous agreement with a proposed PET-signalling mechanism. More interestingly, pyrazoloquinoline PQ 2 performed as a dual emissive sensor with a high fluorescence output for both states of the detection system: bound and unbound. In this case, the presence of bivalent Ca 2+ cations alternated the nature of the excited state of the fluorophore from the low-lying ICT state to the blue-shifted LE state, with a significant enhancement in the emission (from Φf = 0.18 to Φf = 0.35 in acetonitrile) at the same time. In contrast, the addition of Na + ions to PQ 2 did not change its spectral characteristics markedly. Since the aforementioned studies on pyrazoloquinoline-based sensors were reported, almost a decade passed until this stem was followed. Then, between 2010 and 2013, Mac and co-workers published a series of articles on ion-sensitive pyrazoloquinolines, which varied by the molecular architecture of the receptor unit (see Figure 16b ) [175] [176] [177] . All of the sensors presented (PQ 1a-d) were designed for PET signalling, and they maintained the connection between the receptor unit and the pyrazoloquinoline chromophore via the non-conjugated methylene spacer. In addition, the authors extended their studies to a wide range of metal cations, including monovalent Li + , Na + and Ag + , and bivalent Ca 2+ , Ba 2+ , Mg 2+ , Zn 2+ , Cd 2+ and Pb 2+ cations. The results obtained were consistent, which showed that these "turn-on" fluorescent cation indicators were more sensitive to the presence of bivalent cations than to monovalent species. Interestingly, for compound PQ 1c, an increased sensitivity and selectivity to Zn 2+ and Mg 2+ arose from a predominant complexation of these cations with two molecules of the sensing system. Furthermore, noticeable bathochromic shifts of the fluorescence bands were observed for M2Zn 2+ and M2Mg 2+ complexes. These findings were explained by the formation of excimer species [M 2+ (MM)]*, which was confirmed by quantum chemical calculations [177] . In 2013, the same research group demonstrated a detailed study on the pyrazoloquinoline derivative PQ 1d, which was a direct precursor for the synthesis of the aza-crown fluorescence probe PQ 1, previously reported by Rurack [5] . It was found that this compound can act as a highly efficient Since the aforementioned studies on pyrazoloquinoline-based sensors were reported, almost a decade passed until this stem was followed. Then, between 2010 and 2013, Mac and co-workers published a series of articles on ion-sensitive pyrazoloquinolines, which varied by the molecular architecture of the receptor unit (see Figure 16b ) [175] [176] [177] . All of the sensors presented (PQ 1a-d) were designed for PET signalling, and they maintained the connection between the receptor unit and the pyrazoloquinoline chromophore via the non-conjugated methylene spacer. In addition, the authors extended their studies to a wide range of metal cations, including monovalent Li + , Na + and Ag + , and bivalent Ca 2+ , Ba 2+ , Mg 2+ , Zn 2+ , Cd 2+ and Pb 2+ cations. The results obtained were consistent, which showed that these "turn-on" fluorescent cation indicators were more sensitive to the presence of bivalent cations than to monovalent species. Interestingly, for compound PQ 1c, an increased sensitivity and selectivity to Zn 2+ and Mg 2+ arose from a predominant complexation of these cations with two molecules of the sensing system. Furthermore, noticeable bathochromic shifts of the fluorescence bands were observed for M 2 Zn 2+ and M 2 Mg 2+ complexes. These findings were explained by the formation of excimer species [M 2+ (MM)]*, which was confirmed by quantum chemical calculations [177] . In 2013, the same research group demonstrated a detailed study on the pyrazoloquinoline derivative PQ 1d, which was a direct precursor for the synthesis of the aza-crown fluorescence probe PQ 1, previously reported by Rurack [5] . It was found that this compound can act as a highly efficient sensor for many bivalent cations and that, more importantly, its selectivity can be easily enhanced by the addition of small amounts of water to the fluorescing medium.

Three years later, Uchacz et al. investigated a series of donor-acceptor 1H-pyrazolo [3,4b] quinolines that were substituted with different amine donors (i.e., N,N-dimethylamine, N,N-diphenylamine, N,N-phenyl-1-naphthylamine and carbazole groups), with the aim of implementing them as pH-sensitive molecular logic switches [178] . The authors showed that, in the presence of trifluoroacetic acid (the input signal), the fluorescence of the investigated pyrazoloquinolines was almost completely quenched, which was due to the formation of a nonemissive protonated adduct. Interestingly, pyrazoloquinoline substituted with the N,N-dimethylamine group presented a more advanced ternary logic behavior (see Figure 17 ). The nonprotonated state of this compound showed considerable fluorescence (yellow emission, first logic value), which, upon the first protonation of the nitrogen of the dimethylamino moiety, shifted hypsochromically and slightly decreased (bluishgreen emission, second logic value). The second protonation, which involved the nitrogen of the quinoline core, quenched the fluorescence quantitatively (no emission, third logic value). Basically, reading the fluorescence response as an output that is dependent on the presence of proton input signals yielded functional luminescent molecules with the potential for multilevel logic switching, which ranged from binary to ternary responses. ., N,N-dimethylamine, N,N-diphenylamine, N,N-phenyl-1-naphthylamine and carbazole groups) , with the aim of implementing them as pH-sensitive molecular logic switches [178] . The authors showed that, in the presence of trifluoroacetic acid (the input signal), the fluorescence of the investigated pyrazoloquinolines was almost completely quenched, which was due to the formation of a nonemissive protonated adduct. Interestingly, pyrazoloquinoline substituted with the N,N-dimethylamine group presented a more advanced ternary logic behavior (see Figure 17 ). The nonprotonated state of this compound showed considerable fluorescence (yellow emission, first logic value), which, upon the first protonation of the nitrogen of the dimethylamino moiety, shifted hypsochromically and slightly decreased (bluish-green emission, second logic value). The second protonation, which involved the nitrogen of the quinoline core, quenched the fluorescence quantitatively (no emission, third logic value). Basically, reading the fluorescence response as an output that is dependent on the presence of proton input signals yielded functional luminescent molecules with the potential for multilevel logic switching, which ranged from binary to ternary responses. With regard to all of these results, it can be concluded that the scope of pyrazoloquinoline-based fluorescence probes is still amenable to further investigation. For instance, the up-to-date studies were mainly focused on the PET-signalling mechanism, with only minute mention of the intramolecular rotation-dependent quenching of the excited ICT states. Currently, a plethora of photophysical studies are devoted to many different ICT state-related phenomena, such as TICT, PICT, PPT, TADF, umpolung-ICT and so forth [179] [180] [181] [182] [183] , which can be used as output signals for analyte compounds. Furthermore, the presented studies focus mostly on inorganic ion-sensing, which leaves future prospects for the many biomedical applications of pyrazoloquinoline fluorophores, such as fluorescence bioimaging, photosensitized diagnoses or therapies.

Nitrogen-heterocycles are the most common heterocyclic compounds that occur in living organisms [184] , and they are also very often tested as compounds that show biological activity [185, 186] . Thus, it is not unusual that pyrazoloquinoline derivatives have attracted the attention of researchers who deal with the biological activity of organic compounds. It is advisable to divide pyrazoloquinoline derivatives into groups according to the kind of biological activity that they possess. With regard to all of these results, it can be concluded that the scope of pyrazoloquinolinebased fluorescence probes is still amenable to further investigation. For instance, the upto-date studies were mainly focused on the PET-signalling mechanism, with only minute mention of the intramolecular rotation-dependent quenching of the excited ICT states. Currently, a plethora of photophysical studies are devoted to many different ICT state-related phenomena, such as TICT, PICT, PPT, TADF, umpolung-ICT and so forth [179] [180] [181] [182] [183] , which can be used as output signals for analyte compounds. Furthermore, the presented studies focus mostly on inorganic ion-sensing, which leaves future prospects for the many biomedical applications of pyrazoloquinoline fluorophores, such as fluorescence bioimaging, photosensitized diagnoses or therapies.

Nitrogen-heterocycles are the most common heterocyclic compounds that occur in living organisms [184] , and they are also very often tested as compounds that show biological activity [185, 186] . Thus, it is not unusual that pyrazoloquinoline derivatives have attracted the attention of researchers who deal with the biological activity of organic compounds. It is advisable to divide pyrazoloquinoline derivatives into groups according to the kind of biological activity that they possess.

The method of synthesis that was developed by Stein et al. and Crenshaw et al. [29, 30] produced, inter alia, 4-chloro-1,3-dimethyl-1H-pyrazolo [3,4-b] quinolines, which, after functionalization with different amine derivatives (Figure 18 ), were tested for their hypolipemic and hypocholesteremic activity in rats [187] . 

The method of synthesis that was developed by Stein et al. and Crenshaw et al. [29, 30] produced, inter alia, 4-chloro-1,3-dimethyl-1H-pyrazolo [3,4-b] quinolines, which, after functionalization with different amine derivatives (Figure 18 ), were tested for their hypolipemic and hypocholesteremic activity in rats [187] . The compounds were suspended in a carboxymethyl cellulose solution at a dose of 100-400 mg/kg, compared to a carboxymethyl cellulose solution only, and were administrated to rats daily for 4 days. After the administration, the rats were tested for their cholesterol and phospholipid concentrations in serum, and the results show that, with the maximum dose of 400 mg/kg, the concentration was reduced significantly: by −51% for cholesterol and by −47% for phospholipids.

Interferons are an important group of signalling proteins that are released by cells in response to some viruses [188] , and interferon-inducing drugs are one of the weapons in the fight against viruses [189] (Figure 19 ), which was obtained by Stein et al. [29] , was tested as a low-molecular-weight interferon inducer by Siminoff et al. [190] . The compound was administrated to female mice by the oral or parenteral route, and the administration was repeated. In concentrations of 200 mg/kg or higher, the response of the interferon production was very high, and it protected the mouse L cells against infection by the vesicular stomatotitis virus or the mouse picornavirus. The animals also became hyperesponsive to repeated stimulation. The following research in the Siminoff group also showed that other derivatives of 1,3-dimethyl-1H-pyrazolo [3,4-b] quinoline, which contained the substituent at the 4 position, which is attached by the NH moiety, and with a side chain of at least three carbons and terminating with the second amino function (Figure 19b) , also have significant interferon-inducing activity [30] . In the subsequent research, Siminoff analyzed which cells in mice are the major target for interferon induction The compounds were suspended in a carboxymethyl cellulose solution at a dose of 100-400 mg/kg, compared to a carboxymethyl cellulose solution only, and were administrated to rats daily for 4 days. After the administration, the rats were tested for their cholesterol and phospholipid concentrations in serum, and the results show that, with the maximum dose of 400 mg/kg, the concentration was reduced significantly: by −51% for cholesterol and by −47% for phospholipids.

Interferons are an important group of signalling proteins that are released by cells in response to some viruses [188] , and interferon-inducing drugs are one of the weapons in the fight against viruses [189] (Figure 19 ), which was obtained by Stein et al. [29] , was tested as a low-molecular-weight interferon inducer by Siminoff et al. [190] .

The method of synthesis that was developed by Stein et al. and Crenshaw et al. [29, 30] produced, inter alia, 4-chloro-1,3-dimethyl-1H-pyrazolo [3,4-b] quinolines, which, after functionalization with different amine derivatives (Figure 18 ), were tested for their hypolipemic and hypocholesteremic activity in rats [187] . The compounds were suspended in a carboxymethyl cellulose solution at a dose of 100-400 mg/kg, compared to a carboxymethyl cellulose solution only, and were administrated to rats daily for 4 days. After the administration, the rats were tested for their cholesterol and phospholipid concentrations in serum, and the results show that, with the maximum dose of 400 mg/kg, the concentration was reduced significantly: by −51% for cholesterol and by −47% for phospholipids.

Interferons are an important group of signalling proteins that are released by cells in response to some viruses [188] , and interferon-inducing drugs are one of the weapons in the fight against viruses [189] (Figure 19 ), which was obtained by Stein et al. [29] , was tested as a low-molecular-weight interferon inducer by Siminoff et al. [190] . The compound was administrated to female mice by the oral or parenteral route, and the administration was repeated. In concentrations of 200 mg/kg or higher, the response of the interferon production was very high, and it protected the mouse L cells against infection by the vesicular stomatotitis virus or the mouse picornavirus. The animals also became hyperesponsive to repeated stimulation. The following research in the Siminoff group also showed that other derivatives of 1,3-dimethyl-1H-pyrazolo [3,4-b] quinoline, which contained the substituent at the 4 position, which is attached by the NH moiety, and with a side chain of at least three carbons and terminating with the second amino function (Figure 19b) , also have significant interferon-inducing activity [30] . In the subsequent research, Siminoff analyzed which cells in mice are the major target for interferon induction The compound was administrated to female mice by the oral or parenteral route, and the administration was repeated. In concentrations of 200 mg/kg or higher, the response of the interferon production was very high, and it protected the mouse L cells against infection by the vesicular stomatotitis virus or the mouse picornavirus. The animals also became hyperesponsive to repeated stimulation. The following research in the Siminoff group also showed that other derivatives of 1,3-dimethyl-1H-pyrazolo [3,4-b] quinoline, which contained the substituent at the 4 position, which is attached by the NH moiety, and with a side chain of at least three carbons and terminating with the second amino function (Figure 19b) , also have significant interferon-inducing activity [30] . In the subsequent research, Siminoff analyzed which cells in mice are the major target for interferon induction by 4-[(3-(dimethyloamino)propyloamino]-1,3-dimethyl-1H-pyrazolo [3,4-b] quinoline (Figure 19a ) [191] . The analysis of the results shows that the type of adherent leukocytes that are resident in the spleen is a major target of interferon induction. The other derivatives (Figure 19b) were also tested by Siminoff and Crenshaw in the cultures of spleen adherent leukocytes [192] . The results show that some of the derivatives also showed high interferon-inducing activity. One of the derivatives, 4-[(3-(dimethyloamino)propyloamino] -1,3,7-trimethyl-1H-pyrazolo [3,4-b] quinoline hydrochloride (Figure 19c ), was also tested by Kern et al. [193] , and again, the compound induced high levels of circulating interferon, which effected, with significantly reduced mortality, the mice that were infected with the Rochester mouse virus, Herpesvirus hominis, Semliki forest virus and the vesicular stomatitis virus. The authors also observed the strong hyporeactivity of the interferon after multiple doses of 4-[(3-(dimethyloamino)propyloamino]-1,3,7-trimethyl-1H-pyrazolo [3,4-b] quinoline hydrochloride.

Many virus infections in humans are self-cured by the immune system of the organism, and, for many others, vaccinations provide immunity to infection. However, there are some diseases that must be cured by the use of antivirial drugs (e.g., HIV, herpes viruses, hepatitis). A huge family of 1H-pyrazolo [3,4-b] quinoline derivatves (Figure 20 ), which were obtained by the method of Stein et al. [29] and then functionalised, were synthesised and tested for antiviral activity by the group from the Research Institute for Pharmacy and Biochemistry in Prague in the 1980s [194] [195] [196] [197] [198] [199] [200] [201] .

leukocytes that are resident in the spleen is a major target of interferon induction. other derivatives (Figure 19b) were also tested by Siminoff and Crenshaw in the cultu of spleen adherent leukocytes [192] . The results show that some of the derivatives showed high interferon-inducing activity. One of the derivatives, 4-[(3-(dimethylo ino)propyloamino] -1,3,7-trimethyl-1H-pyrazolo [3,4-b] quinoline hydrochloride (Fig  19c) , was also tested by Kern et al. [193] , and again, the compound induced high level circulating interferon, which effected, with significantly reduced mortality, the mice were infected with the Rochester mouse virus, Herpesvirus hominis, Semliki forest v and the vesicular stomatitis virus. The authors also observed the strong hyporeactivit the interferon after multiple doses of 4-[(3-(dimethyloamino)propyloamino]-1,3,7-tri thyl-1H-pyrazolo [3,4-b] quinoline hydrochloride.

Many virus infections in humans are self-cured by the immune system of the org ism, and, for many others, vaccinations provide immunity to infection. However, th are some diseases that must be cured by the use of antivirial drugs (e.g., HIV, herpes ruses, hepatitis). A huge family of 1H-pyrazolo [3,4-b] quinoline derivatves (Figure which were obtained by the method of Stein et al. [29] and then functionalised, were s thesised and tested for antiviral activity by the group from the Research Institute for P macy and Biochemistry in Prague in the 1980s [194] [195] [196] [197] [198] [199] [200] [201] . [194, 198] . keto derivatives ( Figure 21) were tested against the same viruses as aniline-derivati against the A2-Hongkong virus and against the encephalomyocarditidis (EMC) viru vivo in mice, and after oral or subcutaneous administration. Anilino derivatives were tested against the A2-Hongkong virus and against the encephalomyocarditidis (EMC) virus in vivo in mice. Some of them showed high activity against one or the other virus, and some of them were effective against both. In the case of 4-[(4-methylphenyl)amino]-and 4-[(5-methoxy-2-pyrimidinum)amino]-derivatives, which were administrated orally, the survival time was extended after infection with the A2-Hongkong virus by 50 and 67 days, respectively. In the case of 4-[(4-hydroxyphenyl)amino]-, 4-[(4-octadecaoxyphenyl)amino]-and 4-[(3,4-methylenedioxyphenyl)amino]-derivatives that were administrated subcutaneously, the time of survival against the EMC virus was increased by 70, 83 and 95 days, respectively [194, 198] . The keto derivatives ( Figure 21) were tested against the same viruses as aniline-derivatives: against the A2-Hongkong virus and against the encephalomyocarditidis (EMC) virus in vivo in mice, and after oral or subcutaneous administration. and the vesicular stomatitis virus. The authors also observed the strong hypor the interferon after multiple doses of 4-[(3-(dimethyloamino)propyloamino]thyl-1H-pyrazolo [3,4-b] quinoline hydrochloride.

Many virus infections in humans are self-cured by the immune system of ism, and, for many others, vaccinations provide immunity to infection. How are some diseases that must be cured by the use of antivirial drugs (e.g., HIV ruses, hepatitis). A huge family of 1H-pyrazolo [3,4-b] quinoline derivatves ( which were obtained by the method of Stein et al. [29] and then functionalised thesised and tested for antiviral activity by the group from the Research Institu macy and Biochemistry in Prague in the 1980s [194] [195] [196] [197] [198] [199] [200] [201] . The most potent against the A2-Hongong virus was 4,9-dihydro-3,9-dimethyl-4oxo-1H(2H)-pyrazolo[3,4-b]quinoline, which extended the survival by 55%. In the case of the EMC virus, the compounds were much more effective, and for 4,9-dihydro-3methyl-4-oxo-1H(2H)-pyrazolo [3,4-b] quinoline and 4,9-dihydro-6-methoxy-3-methyl-4oxo-1H(2H)-pyrazolo [3,4-b] quinoline, the survival was extended by 96% or by 80-100%, respectively [195, 200, 201] . Some of the compounds were also tested in vitro against different microbes (e.g., Streptococcus faecalis, Escherichia coli or Candida albicans); however, none of the studied derivatives had significant inhibitory effects [195] . The authors from the Research Institute for Pharmacy and Biochemistry in Prague were so satisfied with the results that they obtained for some of the tested pyrazoloquinoline derivatives that they patented them in Czechoslovakia [202] [203] [204] [205] [206] [207] [208] . One of the compounds that was obtained by Rádl et al. [194] , 4-[(4-methoxyphenyl)amino]-1,3-dimethyl-1H-pyrazolo[3,4-b]quinoline ( Figure 22 , R = OMe), was included in the modeling procedure for the binding site identification and the docking study of human β-arrestin by Chintha et al. [209] . The most potent against the A2-Hongong virus was 4,9-dihydro-3,9-dimethyl-4-oxo-1H(2H)-pyrazolo [3,4-b] quinoline, which extended the survival by 55%. In the case of the EMC virus, the compounds were much more effective, and for 4,9-dihydro-3-methyl-4oxo-1H(2H)-pyrazolo [3,4-b] quinoline and 4,9-dihydro-6-methoxy-3-methyl-4-oxo-1H(2H)-pyrazolo [3,4-b] quinoline, the survival was extended by 96% or by 80-100%, respectively [195, 200, 201] . Some of the compounds were also tested in vitro against different microbes (e.g., Streptococcus faecalis, Escherichia coli or Candida albicans); however, none of the studied derivatives had significant inhibitory effects [195] . The authors from the Research Institute for Pharmacy and Biochemistry in Prague were so satisfied with the results that they obtained for some of the tested pyrazoloquinoline derivatives that they patented them in Czechoslovakia [202] [203] [204] [205] [206] [207] [208] . One of the compounds that was obtained by Rádl et al. [194] , 4-[(4-methoxyphenyl)amino]-1,3-dimethyl-1H-pyrazolo[3,4-b]quinoline ( Figure 22 , R = OMe), was included in the modeling procedure for the binding site identification and the docking study of human β-arrestin by Chintha et al. [209] . The most potent against the A2-Hongong virus was 4,9-dihydro-3,9-dimethyl-4-oxo-1H(2H)-pyrazolo [3,4-b] quinoline, which extended the survival by 55%. In the case of the EMC virus, the compounds were much more effective, and for 4,9-dihydro-3-methyl-4oxo-1H(2H)-pyrazolo [3,4-b] quinoline and 4,9-dihydro-6-methoxy-3-methyl-4-oxo-1H(2H)-pyrazolo [3,4-b] quinoline, the survival was extended by 96% or by 80-100%, respectively [195, 200, 201] . Some of the compounds were also tested in vitro against different microbes (e.g., Streptococcus faecalis, Escherichia coli or Candida albicans); however, none of the studied derivatives had significant inhibitory effects [195] . The authors from the Research Institute for Pharmacy and Biochemistry in Prague were so satisfied with the results that they obtained for some of the tested pyrazoloquinoline derivatives that they patented them in Czechoslovakia [202] [203] [204] [205] [206] [207] [208] . One of the compounds that was obtained by Rádl et al. [194] , 4-[(4-methoxyphenyl)amino]-1,3-dimethyl-1H-pyrazolo[3,4-b]quinoline ( Figure 22 , R = OMe), was included in the modeling procedure for the binding site identification and the docking study of human β-arrestin by Chintha et al. [209] . In vitro tests were performed with African green monkey kidney (Vero) cells, human diploid lung (WI-38) cells, human epithelial (HeLa) cells and human foreskin fibroblast (FS-85) cells. The monolayers of the cells were infected with HSV-2 in the presence or absence of the compounds SCH 43478, 46792 and 49286. The results were compared with those that were obtained with Acyclovir (ACV), which is the most popular drug that is used against herpes simplex. The inhibition of the HSV-2 plaque formation in Vero cells was achieved with concentrations lower than those for ACV; however, for the other cell lines, ACV is more effective. The cytotoxicity of all of the studied compounds against the tested cell lines was comparable to the effect of ACV. It is important to say that the compounds of interest were effective only when added shortly after infection; if added after 3 h or later, they were ineffective, which is a much worse result than that obtained for the ACV. Another broad group of 3-amino-1H-pyrazolo [3,4-b] quinolines ( Figure 24 ) were studied by Bell and Ackerman [214] .

In vitro tests were performed with African green monkey kidney (Vero) cells, human diploid lung (WI-38) cells, human epithelial (HeLa) cells and human foreskin fibroblast (FS-85) cells. The monolayers of the cells were infected with HSV-2 in the presence or absence of the compounds SCH 43478, 46792 and 49286. The results were compared with those that were obtained with Acyclovir (ACV), which is the most popular drug that is used against herpes simplex. The inhibition of the HSV-2 plaque formation in Vero cells was achieved with concentrations lower than those for ACV; however, for the other cell lines, ACV is more effective. The cytotoxicity of all of the studied compounds against the tested cell lines was comparable to the effect of ACV. It is important to say that the compounds of interest were effective only when added shortly after infection; if added after 3 h or later, they were ineffective, which is a much worse result than that obtained for the ACV. Another broad group of 3-amino-1H-pyrazolo [3,4-b] quinolines ( Figure 24 ) were studied by Bell and Ackerman [214] . The authors tested the synthesised compounds against HSV-2 in vitro on mouse emryo fibroblast monolayers. Some of the studied compounds exhibited high activity (comparable or higher than that of Acyclovir), but they were never tested again. A different group of researchers synthesised 3-amino-1H-pyrazolo [3,4-b] quinoline that was derivatived with monosaccharides at the amino group (Figure 25 ), and they tested those against herpes simplex virus type 1 (HSV-1) [215] . African green monkey kidney (Vero) cells were infected with HSV-1. From the tested group, most of the compounds did not show significant cytotoxicity at the concentrtations that are safe for living cells. Only two derivatives were borderline cytotoxic: 7-methyland 7-methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline that was derivatised with pentoses. The authors from the same research group also tested another group of derivatives, and they found that simple 7-methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline has an in vitro anti-HSV-1 activity that is comparable to Acyclovir [216] . The authors also show that the compound of interest has low toxicity (tested in vivo in male mice), even when The authors tested the synthesised compounds against HSV-2 in vitro on mouse emryo fibroblast monolayers. Some of the studied compounds exhibited high activity (comparable or higher than that of Acyclovir), but they were never tested again. A different group of researchers synthesised 3-amino-1H-pyrazolo [3,4-b] quinoline that was derivatived with monosaccharides at the amino group (Figure 25 ), and they tested those against herpes simplex virus type 1 (HSV-1) [215] .

used against herpes simplex. The inhibition of the HSV-2 plaque formation in Ver was achieved with concentrations lower than those for ACV; however, for the oth lines, ACV is more effective. The cytotoxicity of all of the studied compounds again tested cell lines was comparable to the effect of ACV. It is important to say that the pounds of interest were effective only when added shortly after infection; if added h or later, they were ineffective, which is a much worse result than that obtained f ACV. Another broad group of 3-amino-1H-pyrazolo [3,4-b] quinolines ( Figure 24 ) studied by Bell and Ackerman [214] . [214] The authors tested the synthesised compounds against HSV-2 in vitro on m emryo fibroblast monolayers. Some of the studied compounds exhibited high a (comparable or higher than that of Acyclovir), but they were never tested again. A ent group of researchers synthesised 3-amino-1H-pyrazolo [3,4-b] quinoline that w rivatived with monosaccharides at the amino group (Figure 25 ), and they tested against herpes simplex virus type 1 (HSV-1) [215] . African green monkey kidney (Vero) cells were infected with HSV-1. From the group, most of the compounds did not show significant cytotoxicity at the concentrt that are safe for living cells. Only two derivatives were borderline cytotoxic: 7-m and 7-methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline that was derivatised with pen The authors from the same research group also tested another group of derivative they found that simple 7-methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline has an in anti-HSV-1 activity that is comparable to Acyclovir [216] . The authors also show th compound of interest has low toxicity (tested in vivo in male mice), even African green monkey kidney (Vero) cells were infected with HSV-1. From the tested group, most of the compounds did not show significant cytotoxicity at the concentrtations that are safe for living cells. Only two derivatives were borderline cytotoxic: 7-methyland 7-methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline that was derivatised with pentoses. The authors from the same research group also tested another group of derivatives, and they found that simple 7-methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline has an in vitro anti-HSV-1 activity that is comparable to Acyclovir [216] . The authors also show that the compound of interest has low toxicity (tested in vivo in male mice), even when administrated through the parenteral route (nontoxic up to 80 mg/kg). The compounds that were obtained by Bekhit et al. [215] ( Figure 25 ) were tested by Arif et al. for their potential cytotoxic activity [217, 218] . At a 100 µM concentration, some of the compounds showed high cytotoxicity against human breast carcinoma cell lines (MCF-7 and MDA-MB-231); however, at the same time, they were comparably cytotoxic to normal human breast epithelial cell lines (MCF-10A and MCF-12A). The 7-Methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline antiviral activity against HIV Type 1 was tested together with other different heterocyclic compounds [219] . Unfortunately, the compound did not show significant activity against that type of virus.

Because of the rising bacterial resistance to antibiotics [220] , there is a constant need to invent new drugs. Pyrazoloquinoline derivatives have been also tested in this field. A group of pyrazoloquinoline derivatives was tested by El-Sayed and Aboul-Enein [221] . The authors started with 3-amino-1H-pyrazolo [3,4-b] quinoline and they substituted it at the amino group ( Figure 26 ). that were obtained by Bekhit et al. [215] ( Figure 25 ) were tested by Arif et al. for their potential cytotoxic activity [217, 218] . At a 100 μM concentration, some of the compounds showed high cytotoxicity against human breast carcinoma cell lines (MCF-7 and MDA-MB-231); however, at the same time, they were comparably cytotoxic to normal human breast epithelial cell lines (MCF-10A and MCF-12A). The 7-Methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline antiviral activity against HIV Type 1 was tested together with other different heterocyclic compounds [219] . Unfortunately, the compound did not show significant activity against that type of virus.

Because of the rising bacterial resistance to antibiotics [220] , there is a constant need to invent new drugs. Pyrazoloquinoline derivatives have been also tested in this field. A group of pyrazoloquinoline derivatives was tested by El-Sayed and Aboul-Enein [221] . The authors started with 3-amino-1H-pyrazolo [3,4-b] quinoline and they substituted it at the amino group ( Figure 26 ). The compounds were then tested against E. coli, S. aureus, C. albicans and A. niger, and they were compared with ampicilin and ketoconazole. The preliminary results indicated that none of the tested compounds had activity higher than ampicilin against E. coli. 1-(4fluorophenyl)-and 1-(4-nitrophenyl)-3-amino-1H-pyrazolo [3,4-b] quinoline achieved results that were comparable to ampicilin against S. aureus. Both compounds also have high activity against C. albicans and A. niger, with the second of them even higher than ketoconazole. In the case of A. niger, 1-(4-chlorophenyl)-3-amino-1H-pyrazolo [3,4-b] quinoline also showed high activity. Another family of differently substituted 3-amino-1H-pyrazolo- [3,4-b] quinolines was synthesised by Lapa et al. [222] . Among the group, one compound, (Figure 27 ) exhibited in vitro activity against S. aureus, S. epidermidis and S. pneumonia that was comparable to Kanamycin (MIC = 4.0-8.0 μg/mL). Against Mycobacterium smegmatis, the compound was even more active than Kanamycin. A different amino derivative was tested by Hamama et al. [54] . The authors used the Path 3 synthetic methodology (Figure 3 ), reacted arylidene compound 74 with 1,4phenylenediamine and obtained 6-amino-3-methyl-1,4-diphenyl-1H-pyrazolo- [3,4b] quinoline ( Figure 28 ). The compounds were then tested against E. coli, S. aureus, C. albicans and A. niger, and they were compared with ampicilin and ketoconazole. The preliminary results indicated that none of the tested compounds had activity higher than ampicilin against E. coli. 1-(4-fluorophenyl)-and 1-(4-nitrophenyl)-3-amino-1H-pyrazolo [3,4-b] quinoline achieved results that were comparable to ampicilin against S. aureus. Both compounds also have high activity against C. albicans and A. niger, with the second of them even higher than ketoconazole. In the case of A. niger, 1-(4-chlorophenyl)-3-amino-1H-pyrazolo [3,4-b] quinoline also showed high activity. Another family of differently substituted 3-amino-1H-pyrazolo- [3,4-b] quinolines was synthesised by Lapa et al. [222] . Among the group, one compound, (Figure 27 ) exhibited in vitro activity against S. aureus, S. epidermidis and S. pneumonia that was comparable to Kanamycin (MIC = 4.0-8.0 µg/mL).

showed high cytotoxicity against human breast carcinoma cell lines (MCF-7 and MDA-MB-231); however, at the same time, they were comparably cytotoxic to normal human breast epithelial cell lines (MCF-10A and MCF-12A). The 7-Methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline antiviral activity against HIV Type 1 was tested together with other different heterocyclic compounds [219] . Unfortunately, the compound did not show significant activity against that type of virus.

Because of the rising bacterial resistance to antibiotics [220] , there is a constant need to invent new drugs. Pyrazoloquinoline derivatives have been also tested in this field. A group of pyrazoloquinoline derivatives was tested by El-Sayed and Aboul-Enein [221] . The authors started with 3-amino-1H-pyrazolo [3,4-b] quinoline and they substituted it at the amino group ( Figure 26 ). The compounds were then tested against E. coli, S. aureus, C. albicans and A. niger, and they were compared with ampicilin and ketoconazole. The preliminary results indicated that none of the tested compounds had activity higher than ampicilin against E. coli. 1-(4fluorophenyl)-and 1-(4-nitrophenyl)-3-amino-1H-pyrazolo [3,4-b] quinoline achieved results that were comparable to ampicilin against S. aureus. Both compounds also have high activity against C. albicans and A. niger, with the second of them even higher than ketoconazole. In the case of A. niger, 1-(4-chlorophenyl)-3-amino-1H-pyrazolo [3,4-b] quinoline also showed high activity. Another family of differently substituted 3-amino-1H-pyrazolo- [3,4-b] quinolines was synthesised by Lapa et al. [222] . Among the group, one compound, (Figure 27 ) exhibited in vitro activity against S. aureus, S. epidermidis and S. pneumonia that was comparable to Kanamycin (MIC = 4.0-8.0 μg/mL). Against Mycobacterium smegmatis, the compound was even more active than Kanamycin. A different amino derivative was tested by Hamama et al. [54] . The authors used the Path 3 synthetic methodology (Figure 3 ), reacted arylidene compound 74 with 1,4phenylenediamine and obtained 6-amino-3-methyl-1,4-diphenyl-1H-pyrazolo- [3,4b] quinoline ( Figure 28 ). Against Mycobacterium smegmatis, the compound was even more active than Kanamycin.

A different amino derivative was tested by Hamama et al. [54] . The authors used the Path 3 synthetic methodology (Figure 3 The in vitro activity of the compound against Bacillus subtilis and Escherichia coli was a little lower than that found for Ampicilin. Pyrazoloquinolines of a totally different structure were studied by Quiroga et al. [118] (Scheme 45). The authors obtained a series of benzo[h]pyrazolo[3,4-b]quinolin-5,6-diones (165), between which 3-methyl-1,4-diphenyl-, 3-methyl-4-(4-methylphenyl)-1-phenyl-and 3-methyl-4-(4-fluorophenyl)-1-phenylseemed to be the most promising and presented the strongest in vitro activity against The in vitro activity of the compound against Bacillus subtilis and Escherichia coli was a little lower than that found for Ampicilin. Pyrazoloquinolines of a totally different struc-ture were studied by Quiroga et al. [118] (Scheme 45). The authors obtained a series of benzo[h]pyrazolo [3,4-b] quinolin-5,6-diones (165) , between which 3-methyl-1,4-diphenyl-, 3-methyl-4-(4-methylphenyl)-1-phenyl-and 3-methyl-4-(4-fluorophenyl)-1-phenyl-seemed to be the most promising and presented the strongest in vitro activity against some Mycobacterium spp. For two active compounds, the authors also presented the XRD measurement results. The results indicate that the research should be continued. Another group of pyrazoloquinoline derivatives that were differently substituted at N-1 ( Figure 29 ) were synthesised and tested by Jitender et al. [83] . The in vitro activity of the compound against Bacillus subtilis and Escherichia coli was a little lower than that found for Ampicilin. Pyrazoloquinolines of a totally different structure were studied by Quiroga et al. [118] (Scheme 45). The authors obtained a series of benzo[h]pyrazolo [3,4-b] quinolin-5,6-diones (165) , between which 3-methyl-1,4-diphenyl-, 3-methyl-4-(4-methylphenyl)-1-phenyl-and 3-methyl-4-(4-fluorophenyl)-1-phenylseemed to be the most promising and presented the strongest in vitro activity against some Mycobacterium spp. For two active compounds, the authors also presented the XRD measurement results. The results indicate that the research should be continued. Another group of pyrazoloquinoline derivatives that were differently substituted at N-1 ( Figure  29 ) were synthesised and tested by Jitender et al. [83] . Figure 30 ), which, with an MIC at 3.9-7.8 μg/mL, was a little worse than the value that was found for Ciprofloxacin (the reference in the study). Better results were obtained in the activity against Candida albicans spp.; for all the tested species, 2-(4-phenyl-3-(trifluoromethyl)-1H-pyrazolo [3,4-b] quinolin-1-yl)-N-(2-(piperazin-1-yl)ethyl) acetamide was as active as the Miconazole biofilm inhibition assay of the studied compound, which was comparable to the results for Ciprofloxacin against Gram-positive and Gram-negative bacteria, and to the results for Miconazole against C. Figure 30 ), which, with an MIC at 3.9-7.8 µg/mL, was a little worse than the value that was found for Ciprofloxacin (the reference in the study). The in vitro activity of the compound against Bacillus subtilis and Escherichia coli was a little lower than that found for Ampicilin. Pyrazoloquinolines of a totally different structure were studied by Quiroga et al. [118] (Scheme 45). The authors obtained a series of benzo[h]pyrazolo [3,4-b] quinolin-5,6-diones (165) , between which 3-methyl-1,4-diphenyl-, 3-methyl-4-(4-methylphenyl)-1-phenyl-and 3-methyl-4-(4-fluorophenyl)-1-phenylseemed to be the most promising and presented the strongest in vitro activity against some Mycobacterium spp. For two active compounds, the authors also presented the XRD measurement results. The results indicate that the research should be continued. Another group of pyrazoloquinoline derivatives that were differently substituted at N-1 ( Figure  29 ) were synthesised and tested by Jitender et al. [83] . Figure 30 ), which, with an MIC at 3.9-7.8 μg/mL, was a little worse than the value that was found for Ciprofloxacin (the reference in the study). Better results were obtained in the activity against Candida albicans spp.; for all the tested species, 2-(4-phenyl-3-(trifluoromethyl)-1H-pyrazolo [3,4-b] quinolin-1-yl)-N-(2-(piperazin-1-yl)ethyl) acetamide was as active as the Miconazole biofilm inhibition assay of the studied compound, which was comparable to the results for Ciprofloxacin against Gram-positive and Gram-negative bacteria, and to the results for Miconazole against C. Better results were obtained in the activity against Candida albicans spp.; for all the tested species, 2-(4-phenyl-3-(trifluoromethyl)-1H-pyrazolo [3,4-b] quinolin-1-yl)-N-(2-(piperazin-1-yl)ethyl) acetamide was as active as the Miconazole biofilm inhibition assay of the studied compound, which was comparable to the results for Ciprofloxacin against Gram-positive and Gram-negative bacteria, and to the results for Miconazole against C. albicans. All of the 32 compounds were also tested for their cytotoxicity against the HeLa, HepG2, A549 and COLO 205 cancer cells lines, but the IC 50 (µM) values had to be at least one level of magnitude higher than those found for 5-fluorouracil (as a reference) in order to attract more attention as an anticancer drug.

Cancer is a leading cause of death (after cardiovascular diseases), and, in 2020, there were nearly 10 million deaths that were attributed to it (WHO). At the moment, world medicine has many anticancer drugs, but most of them are also cytotoxic to normal cells, and especially to those that are rapidly dividing. Thus, there is still a need for new highly selective anticancer drugs [223, 224] . 7-Methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline, which appeared to be as active as Acyclovir against HSV-1 [216] , was also tested as an inhibitor of the growth of cancer cells. Karthikeyan et al. tested the cytotoxicity of a group of 3-amino-1H-pyrazolo [3,4-b] quinolines ( Figure 31 ) against ten cancer cell lines, including breast, colon, prostate, brain and ovarian, in comparison to a noncancerous cell line, the human embryonic kidney [225] .

were nearly 10 million deaths that were attributed to it (WHO). At the moment, world medicine has many anticancer drugs, but most of them are also cytotoxic to normal cells, and especially to those that are rapidly dividing. Thus, there is still a need for new highly selective anticancer drugs [223, 224] . 7-Methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline, which appeared to be as active as Acyclovir against HSV-1 [216] , was also tested as an inhibitor of the growth of cancer cells. Karthikeyan et al. tested the cytotoxicity of a group of 3-amino-1H-pyrazolo [3,4-b] quinolines ( Figure 31 ) against ten cancer cell lines, including breast, colon, prostate, brain and ovarian, in comparison to a noncancerous cell line, the human embryonic kidney [225] . medicine has many anticancer drugs, but most of them are also cytotoxic to normal cells, and especially to those that are rapidly dividing. Thus, there is still a need for new highly selective anticancer drugs [223, 224] . 7-Methoxy-3-amino-1H-pyrazolo [3,4-b] quinoline, which appeared to be as active as Acyclovir against HSV-1 [216] , was also tested as an inhibitor of the growth of cancer cells. Karthikeyan et al. tested the cytotoxicity of a group of 3-amino-1H-pyrazolo [3,4-b] quinolines ( Figure 31 ) against ten cancer cell lines, including breast, colon, prostate, brain and ovarian, in comparison to a noncancerous cell line, the human embryonic kidney [225] . [3,4b] quinoline-4(1H)-one was also found to be the most active in reversing the ABCG-2mediated resistance to mitoxantrone, doxorubicin and cisplatin, which are common anticancer drugs. Mutations in Ras proteins are able to lead to unregulated cell division and are found in a significant number of human cancers [227] . For this reason, the identification of drugs that inhibit, either directly or indirectly, the transforming activity of the Ras protein is important in the search for an effective treatment of cancer [228] . 6-Methoxy-4-[2-[(2hydroxyethoxyl)ethyl]amino]-3-methyl-1H-pyrazolo [3,4-b] quinoline (SCH 51344, Figure 33 ) was one of the compounds that was tested as a possible ras-transformation inhibitor. reversing the ABCG-2-mediated resistance to mitoxantrone, doxorubicin and cisplatin, which are common anticancer drugs. Mutations in Ras proteins are able to lead to unregulated cell division and are found in a significant number of human cancers [227] . For this reason, the identification of drugs that inhibit, either directly or indirectly, the transforming activity of the Ras protein is important in the search for an effective treatment of cancer [228] . Figure 33 ) was one of the compounds that was tested as a possible ras-transformation inhibitor. Kumar et al. carefully studied the mechanism of inhibition [229] [230] [231] [232] . Pyrazoloquinoline SCH 51344, specifically, inhibits the RAS-mediated cell morphology pathway (H-, K-and N-RAS V12-induced membrane ruffling). The treatment of RAS-transformed cells with SCH 51344 restored organised actin filament bundles. Moreover, the anchorage-independent growth of K-RAS, which transformed NIH 3T3 cells and human colon and pancreatic tumorderived cells (DLD-1, Panc-1, SW-480), was inhibited by SCH 51344. The authors also show that SCH 51344 is not cytotoxic to normal cells. Their studies show that the compound selectively suppressed oncogene-transformed growth without the gross effect on the normal signalling pathway. Gelman et al. also found that SCH 51344 suppresses src-, rasand raf -induced oncogenic transformation by more than 90% at a 40 µM concentration of the pyrazoloquinoline [233] . The oncogenic growth potentials of rat-6/ras and /raf are more sensitive to SCH 51344 than rat-6/src cells because they are more dependent on pathways that are blocked by the compound. (S)-Crizotinib was tested as an anticancer drug by Huber et al., and the obtained results were compared to (R) enantiomer and SCH 51344 [234, 235] . The authors, by using the proteomic approach, identified the target of SCH 51344 as the human mutT homologue MTH1 (NUDT1). The analysis of that pyrazoloquinoline was only one step to the main goal, which was the study concerning (S)-crizotinib. SCH 51344 was also one of the compounds that was tested by Ursu and Waldman as a small molecule target that binds to MTH1, with a comparison to (R)-and (S)-crizotinib [236] . The authors tested a few molecules of different structures by linker-based target identification techniques. The authors attached SCH 51344 to sepharose and proved that MTH1 is a primary target of the compound. The result was also confirmed in vitro by isothermal titration calorimetry and an MTH1 catalytic assay. SCH 51344 (6-methoxy-4-[2-[(2-hydroxyethoxyl)ethyl]amino]-3-methyl-1H-pyrazolo [3,4-b] quinoline) is now commercially available as an MTH1 inhibitor [237] . It is in use as one of the reference compounds in research that concerns anticancer drugs [238] [239] [240] [241] [242] [243] . Different pyrazoloquinoline derivatives, functionalized with ribose or morpholine moieties (Figure 34 ), have been also tested as antitumor agents [244] [245] [246] . The mechanism of inhibition is probably the binding to an allosteric region of the Ras p21 protein, which leads to conformational change and prevents the binding of 3 H-GDP to the protein.The best results have been obtained for 1-[4-chloro-3-methyl-6-methoxy-1H-pyrazolo [3,4-b] quinolinyl]-1-riboburanoside-tribenzoate,-tris(2-furoate),-4-(E-2-benzoylethenyl),4-[(1-hydroxy-2-benzoyl)ethyl]-2,3-thiocarbonate: a >70% inhibition at 10, 10.5, 10 and 1.5 μM concentrations, respectively. For the morpholine series, eight derivatives showed >70% inhibition at a <10μM concentration. One of the ways of anticancer drug action is by inducing the apoptosis of tumor cells [247] . 4-Phenylamino pyrazolo [3,4b] quinolines, which have been tested for their antiviral activity [194, 198] , have also The mechanism of inhibition is probably the binding to an allosteric region of the Ras p21 protein, which leads to conformational change and prevents the binding of 3 H-GDP to the protein.The best results have been obtained for 1-[4-chloro-3-methyl-6methoxy-1H-pyrazolo [3,4-b] quinolinyl]-1-riboburanoside-tribenzoate,-tris(2-furoate),-4-(E-2-benzoylethenyl),4-[(1-hydroxy-2-benzoyl)ethyl]-2,3-thiocarbonate: a >70% inhibition at 10, 10.5, 10 and 1.5 µM concentrations, respectively. For the morpholine series, eight derivatives showed >70% inhibition at a <10µM concentration. One of the ways of anticancer drug action is by inducing the apoptosis of tumor cells [247] . 4-Phenylamino pyrazolo [3,4-b] quinolines, which have been tested for their antiviral activity [194, 198] , have also brought attention to themselves as potential apoptosis inducers. Zhang et al. tested a group of N-phenyl-1H-pyrazolo- [3,4-b] quinolin-4-amines ( Figure 35 ) as potent apoptosis inducers [57] . The mechanism of inhibition is probably the binding to an allosteric region of the Ras p21 protein, which leads to conformational change and prevents the binding of 3 H-GDP to the protein.The best results have been obtained for 1-[4-chloro-3-methyl-6-methoxy-1H-pyrazolo [3,4-b] quinolinyl]-1-riboburanoside-tribenzoate,-tris(2-furoate),-4-(E-2-benzoylethenyl),4-[(1-hydroxy-2-benzoyl)ethyl]-2,3-thiocarbonate: a >70% inhibition at 10, 10.5, 10 and 1.5 μM concentrations, respectively. For the morpholine series, eight derivatives showed >70% inhibition at a <10μM concentration. One of the ways of anticancer drug action is by inducing the apoptosis of tumor cells [247] . 4-Phenylamino pyrazolo [3,4b] quinolines, which have been tested for their antiviral activity [194, 198] , have also brought attention to themselves as potential apoptosis inducers. Zhang et al. tested a group of N-phenyl-1H-pyrazolo- [3,4-b] quinolin-4-amines ( Figure 35 ) as potent apoptosis inducers [57] . The authors tested the activity of the synthesised derivatives against the human breast cancer (T47D), colon cancer (HCT116) and liver cancer (SNU 398) cell lines in vitro. The most active against the chosen cancer cells appeared to be 1,3-dimethyl-N-(4-propionylphenyl)-1Hpyrazolo [3,4-b] quinolin-4-amine ( Figure 35 , X = NH, R 1 ,R 2 = Me, R 3 = COEt, R 4 = H), which was about 6 ÷ 13-fold more potent than the reference, N-(4-acetylphenyl)-2,3-dihydro-1Hcyclopenta[b]quinolin-9-amine. The authors also tested the cell proliferation activity of the same compound and they again obtained very promising results; however, the research has not been continued.

Al-Qahtani et al. tested the effect of the series of pyrazoloquinoline derivatives that were obtained earlier by Bekhit et al. [215] (Figure 25 ) on the growth of Leishmania donovani protozoan parasites [248] . The L. donovani (strain DD8) were cultures in Schneider's medium with four different concentrations of drugs (50-400 µM), and they were compared to Amphotericin B-treated cells and to an untreated control. The results indicate that some of the derivatives exhibited an activity that was comparable to the classic drug Amphotericin B; however, the effect was observed after 12 h compared to 6 h for Amph. B. The research has been never repeated.

As schizophrenia is affecting circa 1% of the world's population [249] , and because the already existing drugs enable only a small portion of patients to lead independent lives, there is still the need for improved treatment of schizophrenia. Antipsychotic drugs, which are used in the treatment of schizophrenia, are mostly dopamine 2 (D2) receptor antagonists [250] . PDE10, which is a dual cAMP/cGMP phosphodiesteraze, and which belongs to a family of degradative enzymes that hydrolyse the second messengers that terminate signal transduction, is expressed at high levels in the striatal medium spiny neurons. The inhibition of PDE10, and the following blocking of the degradation of cGMP and cAMP, should mimic the effect of a D2 receptor antagonist and a D1 receptor agonist, which is an ideal profile for an antipsychotic drug. A wide family of different pyrazoloquinoline derivatives was tested in the search for potent PDE10 inhibitors for the treatment of schizophrenia. In the first group, which was analyzed by Yang et al. and Ho et al. [91, 92] , 3-methyl-1H-pyrazolo [3,4-b] quinolines could be found, which were substituted at position 4 with different saturated heterocyclic rings (Figure 36 ). and cAMP, should mimic the effect of a D2 receptor antagonist and a D1 receptor agonist, which is an ideal profile for an antipsychotic drug. A wide family of different pyrazoloquinoline derivatives was tested in the search for potent PDE10 inhibitors for the treatment of schizophrenia. In the first group, which was analyzed by Yang et al. and Ho et al. [91, 92] , 3-methyl-1H-pyrazolo [3,4-b] quinolines could be found, which were substituted at position 4 with different saturated heterocyclic rings ( Figure 36 ). One of the following, N-[6-methoxy-3,8-dimethyl-1H-pyrazolo [3,4-b] quinolinyl]methylmorpholine, was used for co-crystallisation with PDE10A, and the obtained crystals were studied with XRD. The second group was obtained by Ho et al. [92] and it is presented in Figure 38 . The strongest binding affinities were obtained for one 1,4-oxazepane-derivative derivative (Figure 39a) , one piperazine-derivative (Figure 39b) , three piperidine-derivatized One of the following, N-[6-methoxy-3,8-dimethyl-1H-pyrazolo [3,4-b] quinolinyl]methylmorpholine, was used for co-crystallisation with PDE10A, and the obtained crystals were studied with XRD. The second group was obtained by Ho et al. [92] and it is presented in Figure 38 . One of the following, N-[6-methoxy-3,8-dimethyl-1H-pyrazolo [3,4-b] quinolinyl]methylmorpholine, was used for co-crystallisation with PDE10A, and the obtained crystals were studied with XRD. The second group was obtained by Ho et al. [92] and it is presented in Figure 38 . The strongest binding affinities were obtained for one 1,4-oxazepane-derivative derivative (Figure 39a) , one piperazine-derivative (Figure 39b) , three piperidine-derivatized compounds (Figure 39c) , one pyridyne-derivative ( Figure 39d ) and one morpholine-deri- The strongest binding affinities were obtained for one 1,4-oxazepane-derivative derivative (Figure 39a) , one piperazine-derivative (Figure 39b) , three piperidine-derivatized compounds (Figure 39c) , one pyridyne-derivative ( Figure 39d ) and one morpholine-derivatised compound (Figure 39e) with Ki 0.6-5 nM. One of the tested piperazine derivatives had been co-crystallised with PDE10A. Both author groups (Yang et al. and Ho et al.) state that they had been planning to perform in vivo evaluations; however, we could not find any further results concerning the pyrazoloquinolines described above. In the different families of pyrazoloquinoline derivatives, the moiety in position 4 was secondary alcohol with an aromatic moiety ( Figure 40 ) or some other substituents (they are not presented here because of worse results). One of the tested piperazine derivatives had been co-crystallised with PDE10A. Both author groups (Yang et al. and Ho et al.) state that they had been planning to perform in vivo evaluations; however, we could not find any further results concerning the pyrazoloquinolines described above. In the different families of pyrazoloquinoline derivatives, the moiety in position 4 was secondary alcohol with an aromatic moiety ( Figure 40 ) or some other substituents (they are not presented here because of worse results). -quinolinyl]-4-methoxypiperidine, which were studied earlier [91] [92] [93] , have been used as the reference compounds in the search for new PDE10A inhibitors on the basis of the quinazoline derivatives [252] .

Type 2 diabetes is now one of the most prevalent metabolic diseases worldwide [253] . Patients with type 2 diabetes are insulin resistant, and so there is still a need to find drugs that can help to increase insulin sensitivity. C-Jun N-terminal kinase-1 (JNK1) is one of the mitogen-activated protein kinases that probably plays a key role in linking insulin resistance and obesity [254] . Liu et al. synthesised a group of 1,9-dihydro-9-hydroxy pyrazolo[3,4-b]quinolin-4-ones derivatives ( Figure 41 ) and tested themas JNK inhibitors [255] . -quinolinyl]-4-methoxypiperidine, which were studied earlier [91] [92] [93] , have been used as the reference compounds in the search for new PDE10A inhibitors on the basis of the quinazoline derivatives [252] .

Type 2 diabetes is now one of the most prevalent metabolic diseases worldwide [253] . Patients with type 2 diabetes are insulin resistant, and so there is still a need to find drugs that can help to increase insulin sensitivity. C-Jun N-terminal kinase-1 (JNK1) is one of the mitogen-activated protein kinases that probably plays a key role in linking insulin resistance and obesity [254] . Liu et al. synthesised a group of 1,9-dihydro-9-hydroxy pyrazolo[3,4b]quinolin-4-ones derivatives ( Figure 41 ) and tested themas JNK inhibitors [255] .

Patients with type 2 diabetes are insulin resistant, and so there is still a need that can help to increase insulin sensitivity. C-Jun N-terminal kinase-1 (JNK1 mitogen-activated protein kinases that probably plays a key role in linkin sistance and obesity [254] . Liu et al. synthesised a group of 1,9-dihydro-9-h zolo [3,4-b] quinolin-4-ones derivatives ( Figure 41 ) and tested themas JNK inh All of the obtained compounds were tested in a JNK1 enzymatic inhibition assay and in a cell-based assay by measuring the inhibition of the TNFα (tumor necrosis factor)stimulated phosphorylation of c-Jun in HepG2 (human liver cancer) cells. The most potent (JNK1 IC 50 < 1 µM) appeared to be derivatives with R = H, R 2 = Me and R 1 = Et, and Bu, (CH 2 ) 3 CONHMe, (CH 2 ) 2 NHCOMe, (CH 2 ) 3 NHCONHEt or (CH 2 ) 2 NHCOOEt. The authors were also able to grow the co-crystals of one of the derivatives (R = H, R 1 , R 2 = Me, JNK1 IC 50 = 1.22 µM), bound into the ATP site of JNK1, and they analysed the interactions between the protein and the inhibitor. The most potent against JNK1 and also Pc-Jun proved to be the compound that was serendipitously found by the authors who tried to convert carboxylic acid to amine ( Figure 42 ). All of the obtained compounds were tested in a JNK1 enzymatic inhibition assay a in a cell-based assay by measuring the inhibition of the TNFα (tumor necrosis facto stimulated phosphorylation of c-Jun in HepG2 (human liver cancer) cells. The most pote (JNK1 IC50 < 1 μM) appeared to be derivatives with R = H, R 2 = Me and R 1 = Et, and B (CH2)3CONHMe, (CH2)2NHCOMe, (CH2)3NHCONHEt or (CH2)2NHCOOEt. The auth were also able to grow the co-crystals of one of the derivatives (R = H, R 1 , R 2 = Me, JN IC50 = 1.22 μM), bound into the ATP site of JNK1, and they analysed the interactions tween the protein and the inhibitor. The most potent against JNK1 and also Pc-Jun prov to be the compound that was serendipitously found by the authors who tried to conv carboxylic acid to amine ( Figure 42 ). 

The group of pyrazoloquinolines that were substituted by fusing the pyrazol ri with a purine moiety were synthesised by the funcionalisation of 3-amino-1H-pyrazo [3,4-b] quinoline derivatives by El-Sayed et al. (Figure 43 ) [256] . 

The group of pyrazoloquinolines that were substituted by fusing the pyrazol ring with a purine moiety were synthesised by the funcionalisation of 3-amino-1H-pyrazolo- [3,4b] quinoline derivatives by El-Sayed et al. (Figure 43 ) [256] . 

The group of pyrazoloquinolines that were substituted by fusing the pyrazol ring with a purine moiety were synthesised by the funcionalisation of 3-amino-1H-pyrazolo- [3,4-b] quinoline derivatives by El-Sayed et al. (Figure 43 ) [256] . TSPO is an alternative binding site of diazepam [258] ; however, what is more important is that a dramatic increase in the TSPO density occurs in glial cells in response to brain inflammation or injury. Many neuropathological conditions (e.g., Alzheimer's disease, Parkinson's disease) also increase the TSPO density [259] . The authors decided to synthesise the pyrazoloquinolines that are shown in Figure 44 because they are structurally similar to alpidem, which is a known drug that is used for the treatment of anxiety [260] . The authors performed in vitro binding experiments to rat cerebral cortex membranes together with in vivo light/dark box tests in mice (for the most promising derivatives). Both experiments showed that the highest TSPO binding affinities were achieved in vitro by N-R2-2-[2-(4-X-phenyl)-4-methyl-3-oxo-2H-pyrazolo [3,4-b] quinolin-9(3H)-yl]-N-R1-acetamides (Figure 44b ). The IC50 values for all of these derivatives were lower than 1 nM. Moreover, the antianxiety activity of one of the derivatives (N-butyl-2-[2-phenyl-4methyl-3-oxo-2H-pyrazolo[3,4-b]quinolin-9(3H)-yl]-N-methylacetamide) was high, at 10 mg/kg dose, which was comparable to the value that was found for emapunil with the same dose, and for diazepam with a 1 mg/kg dose. The biological activity studies were combined with a detailed structural analysis, including XRD and computational calculations. The obtained results indicate that these group of pyrazoloquinoline derivatives could be a group of new TSPO modulators, and that they are worth further research.

A scintillation proximity assay (SPA) is a biochemical screening radio-isotopic method that is used for the sensitive and rapid measurement of a broad range of biological processes [261] . sulfanyl]-6-methoxy-3-methyl-1H-pyrazolo [3,4-b] quinoline (SCH 46891), which was obtained earlier by Afonso et al. [212] , as one of the tested potent inhibitors of the phosphopeptide binding to the growth factor receptor-bound protein 2 (Grb2) SH2 domain [262] . The studies reveal that the inhibition of the Grb2 SPA by SCH 46891 was light-dependent. The compound was inactive when the assay plates were kept dark. The same light-dependent inhibition property was found for the tyrosine-protein kinase (Syk) SH2 domain via SPA. The authors concluded that the TSPO is an alternative binding site of diazepam [258] ; however, what is more important is that a dramatic increase in the TSPO density occurs in glial cells in response to brain inflammation or injury. Many neuropathological conditions (e.g., Alzheimer's disease, Parkinson's disease) also increase the TSPO density [259] . The authors decided to synthesise the pyrazoloquinolines that are shown in Figure 44 because they are structurally similar to alpidem, which is a known drug that is used for the treatment of anxiety [260] . The authors performed in vitro binding experiments to rat cerebral cortex membranes together with in vivo light/dark box tests in mice (for the most promising derivatives). Both experiments showed that the highest TSPO binding affinities were achieved in vitro by N-R2-2-[2-(4-X-phenyl)-4-methyl-3-oxo-2H-pyrazolo[3,4-b]quinolin-9(3H)-yl]-N-R1-acetamides (Figure 44b ). The IC 50 values for all of these derivatives were lower than 1 nM. Moreover, the antianxiety activity of one of the derivatives (N-butyl-2-[2-phenyl-4-methyl-3-oxo-2H-pyrazolo[3,4-b]quinolin-9(3H)-yl]-N-methylacetamide) was high, at 10 mg/kg dose, which was comparable to the value that was found for emapunil with the same dose, and for diazepam with a 1 mg/kg dose. The biological activity studies were combined with a detailed structural analysis, including XRD and computational calculations. The obtained results indicate that these group of pyrazoloquinoline derivatives could be a group of new TSPO modulators, and that they are worth further research.

A scintillation proximity assay (SPA) is a biochemical screening radio-isotopic method that is used for the sensitive and rapid measurement of a broad range of biological processes [261] . sulfanyl]-6-methoxy-3-methyl-1Hpyrazolo [3,4-b] quinoline (SCH 46891), which was obtained earlier by Afonso et al. [212] , as one of the tested potent inhibitors of the phosphopeptide binding to the growth factor receptor-bound protein 2 (Grb2) SH2 domain [262] . The studies reveal that the inhibition of the Grb2 SPA by SCH 46891 was light-dependent. The compound was inactive when the assay plates were kept dark. The same light-dependent inhibition property was found for the tyrosine-protein kinase (Syk) SH2 domain via SPA. The authors concluded that the light-dependent inhibition mechanism is based on the singlet-oxygen-generating property of SCH 46891 upon irradiation (positive reaction with singlet oxygen trap 2-methylfuran, and the suppression of the inhibition activity by singlet oxygen quenchers).

In 1991, Mehrotra et al. [263] tested 3-amino-6,7-dimethoxy-1H-pyrazolo- [3,4-b] quinoline as a potential pregnancy interceptor in vivo in hamsters and guinea pigs. When the compound was used in the early postimplantation schedule, it interrupted the pregnancy partially; however, it was ineffective in the preimplantation schedule. The same compound was tested in vitro on growing trophoblasts, and it appeared to prevent growth and to cause the degeneration of the cells. The results led the authors to the conclusion that the compound intercepts pregnancy probably through a direct effect on the embryo attachment site. The research was never continued or repeated with that, nor with any other pyrazoloquinoline derivative.

In summary, the main aim of this review was to introduce readers to the methods and procedures that are used for the 1H-pyrazolo [3,4-b] quinoline skeleton synthesis, and to familiarize them with some of the photophysical and biological properties. The work is based on publications that appeared in the years 1911-2021. During this period, approx. 350 publications and patents were published, and, to the best of our knowledge, this is the first study of this type. We wanted to collect, in this review, all of the most important synthetic methods to create a kind of guide for researchers who are involved in the synthesis of nitrogen-condensed heterocycles, and who may decide to direct their interests there.

By studying the development of the synthetic methods of 1H-pyrazolo [3,4-b] quinolines over the last one hundred years, a significant revolution in the approach to preparative methods can be noticed, and especially in the last ten years. In the initial period, syntheses based on classical reactions (e.g., the Friedländer condensation or modifications of the Niementowski reaction) were used. Nowadays, an increasing number of publications can be found that describe three-/four-component reactions, and reactions that are carried out in an aqueous environment with the use of a microwave field, or with ultrasounds and ionic liquids, which are catalysed with palladium compounds and nanoparticles, or that are even mediated with baker's yeast. All of these procedures are part of the so-called "green chemistry".

These methods lead to the synthesis of the basic skeleton, as well as functionalized systems, which offer further possibilities for structural modifications with hydroxyl, halogen or amino moieties. The latter aspect is especially important for chemists in the pharmaceutical industry.

The first synthesised 1H-pyrazolo [3,4-b] quinolines attracted the attention of researchers with their emissive properties, and they were applied as optical brighteners in the 1960s. Later studies show that, in some cases, the quantum yield of the fluorescence was equal to one, and that, in addition, these compounds turned out to be very resistant to temperature or oxidation. For this reason, they were used as emission materials for the fabrication of organic light-emitting diodes (OLEDs) that work on the basis of the phenomenon of fluorescence. In recent years, however, very efficient emissive materials that are based on the phenomenon of phosphorescence or thermally activated delayed fluorescence TADF have appeared, and so it should not be expected that pyrazoloquinolines will be used in the future to fabricate OLEDs. However, by taking into account their very good emissive properties and their stability, it can be expected that they will be used as fluorescent sensors for various analytes, as dyes for synthetic fibers, as dyes for fluorescence microscopy or as materials for the security features of banknotes based on fluorescence.

The third aspect of the use of pyrazoloquinolines are their biological properties, which have been studied since the 1970s, and which were started by Siminoff and Crenshaw, who investigated the antimalarial properties of these compounds. Currently, the spectrum of biological properties is much broader and includes a variety of tests, among which the research on antibacterial, antiviral and anticancer properties is at the forefront. This resulted in, among other things, the commercialization of some preparations, such as, for example, 6-methoxy-4-[2-[(2-hydroxyethoxyl)ethyl]amino]-3-methyl-1H-pyrazolo [3,4b] quinoline, which is now commercially available as an MTH1 inhibitor. Therefore, further studies towards the investigation of novel pharmacologically active 1H-pyrazolo [3,4b] quinolines are highly desirable. 

Über 5-Aminopyrazole und über Iminopyrine. I. Über substituierte 5-Iminopyrazolone und über 5-Aminopyrazole

Kondensacja fenylo-1-metylo-3-okso-5[dwuchydropirazolu] i [chloro-2]-fenylo-1-metylo-3-okso

Reactions in the pyrazolone series. II. Reactions of arylimine derivatives of 1-phenyl-5-methyl-3-pyrazolone with carbanilide or phenyl isocyanate, α-naphthyl isocyanate, and thiocarbanilide or phenyl isothiocyanate

Reactions in the pyrazolone series. III. Reactions of arylimine derivatives of 1-phenyl-3-methyl-5-pyrazolone with carbanilide or phenyl isocyanate, α-naphthyl isocyanate, or with thiocarbanilide or phenyl isothiocyanate

1,3-Diphenyl-1H-pyrazolo[3,4-b]quinoline: A versatile fluorophore for the design of brightly emissive molecular sensors

Kityk, I. 1H-pyrazolo[3,4-b]quinoline and 1H-pyrazolo[3,4-b]quinoxaline derivatives as promising materials for optoelectronic applications

Houben-Weyl Methods of Organic Chemistry

Recent advances in Friedlander reaction

The Friedlander synthesis of quinolines

Friedlander synthesis of poly-substituted quinolones: A mini review

Recent advances in metal-free quinoline synthesis

Amumtaz Alam, M. Green recipes to quinoline: A review

Friedländer Condensation of 1H-Pyrazolin-5-ones with o-Aminobenzaldehydes. Synthesis of 1H-Pyrazolo[3,4-b]quinolines

Developmnet of new dyeing photoinitiators for free radical polymerization based on 1H-pyrazolo[3,4-b]quinoline skeleton. IV

Synthesis of Pyrazolo[3,4-b]quinolines as Luminophores for Electroluminecent Devices

Microwave Assisted Friedländer Condensation Catalyzed by Clay

Spiro compounds for organic-light emitting diodes

Spiro compounds for organic electroluminescence and related applications

Spirobifluorene-based pyrazoloquinolines: Efficient blue electroluminescent materials

Heteroannulations with o-aminoaldehydes

Synthesis of Pyrazolo Heteroaromatic Compounds by Means of 5-Amino-3-methyl-1-phenylpyrazole-4-carbaldehyde

A convenient route for the synthesis of pyrazolo

On 1-methyl-and 1-phenyl-1H-pyrazolo

Quinoline derivatives

Synthesen und reaktionen neuer ortho-kondensierter pyrazoloverbindungen

Attempted Niementowski condensation of anthranilic acid and its ester with 3-methyl-1-phenylpyrazolin-5-one

Antimalarials. 4-Substituted 1H-pyrazolo[3,4-b]quinolones

Interferon inducing activities of derivatives of 1,3-dimethyl-4-(3-dimethylaminopropyloamino)-1H-pyrazolo[3,4-b]quinoline and realted compounds

Further studies on the reaction of N-(2-hydroxyphenyl)anthranilic acid wit acetic anhydride

The ring closure and rearrangement of 1-(2-amino)-benzoyl-1-methylhydrazones of β-dicarbonyl compounds: On the formation and crystal structure of 3a,9a-dihydro-1,3,3a,9a-tetramethyl-4H-pyrazolo[3,4-b]quinolin-4-one

Synthesis of 4-arylamino-5,6,7,8-tetrahydro-1H-pyrazolo[3,4-b]quinolones and the corresponding N-Mannich bases

Synthesis of 4-arylamino-5,6,7,8-tetrahydro-1H-pyrazolo[3,4-b]quinolones and 5,6,7,8-tetrahydrogenated analogs

Synthesis of 7,8-dihydro-6H-pyrazolo[3,4-b]quinolin-5-ones and related derivatives

Synthesis of tricyclic aminopyridines by a cadmium promoted cyclization

Heterocyclic synthesis from 3-amino-4-cyanompyrazole

Synthesis and pharmacological assessment of diversity

The Pfitzinger reaction

Contribution to the knowledge of malonyldiphenylhydrazine and its derivatives

A new synthesis of pyrazolo[3,4-b]quinoline derivatives

New general methods for the substitution of 5-chloropyrazoles. The synthesis of 1,3-dialkyl-5-chloropyrazol-4-yl aryl ketones and new 1,3-dialkyl-2-pyrazolin-5-ones

Design and synthesis of pyrazolone-based compounds as potent blockers of SARS-CoV-2 viral entry into the host cells

Synthesis, electrochemical, photohysical, and electroluminescent properties of organic dyes containing pyrazolo[3,4-b]quinoline chromophore

Synthesis and transformations of chloropyrazolealdehydes

Syntheses von Pyrazolo[3,4-b]chinolinen aus 4-Aroyl-5-chloropyrazolen

Synthesis of polyfunctional substituted pyrazoles

Action des hydrazines sur les acetyl-4-chloro-5(ou 3)methyl-3 (ou 5) pyrazoles: Formation d'une pyrazolo[3,4-b]quinoleine, d'hydrazzones et de cetazines

Unexpected formation of a 10H-pyrido[2,3-h]pyrazolo[3,4-b]quinoline derivative, A new ring system

The synyhesis of 4-aryl-1H-pyrazolo[3,4-b]quinolines by cyclization of 4-arylidenepyrazolin-5-ones with anilines

A versatile synthesis, PM-3-Semiempirical, antibacterial, and antitumor evaluation of some bioactive pyrazoles

Facile and regioselective synthesis of substituted 1H-pyrazolo[3,4-b]quinolones from 2-fluorobenzaldehydes and 1H-pyrazol-5-amines

Reactions of 5-amino-1,2-azoles with aromatic and heterocyclic o-chloroaldehydes

Discovery and structure-Activity relationship of N-phenyl-1H-pyrazolo[3,4-b]quinolin amines as a new series of potent apoptosis inducers

Method for Inhibiting Neoplastic Cells by Exposure to Substituted N-cycloalkylmethyl-1-H-pyrazolo[3,4-b]quinoline-4-amines

Microwave-Assisted palladium mediated efficient synthesis of pyrazolo

A versatile new synthesis of quinolones and related fused pyridines, Part 5. The synthesis of 2-chloroquinolne-3-carbaldehydes

A versatile new synthesis of quinolones and realted fused pyridines. Part 10. Routes to quinolines with fused azacycles

Reactions of carbonyl compounds with(monohalo) methyleniminium salts (Vilsmeier reagents)

The synthesis of pyridines, quinolones and other realted systems by the Vilsmeier and the reversed Vilsmeier method

Syntheses of substituted pyrazolo

Synthesis of pyrazolo[3,4-b]quinolines and their 1-phenyl derivatives

Synthesis of some novel substituted quinolones as potent analgesic agents

Microwave assisted synthesis of pyrazolo[3,4-b]quinoline containing 1,8-naphtyridine moiety

Solvent free synthesis and evaluation of antimicrobial activity of pyrimido

Water mediated one-pot synthetic route for pyrazolo[3,4-b]quinolines

Microwave assisted solvent free synthesis of pyrazolo[3,4-b]quinolones and pyrazolo[3,4-c]pyrzoles using p-TsOH

Synthesis and spectroscopic characterization of some novel pyrazoloquinoline, pyrazolotetrazine and thiazolidinone derivatives

Synthesis of novel N-acylhydrazones and their C-N/N-N bond conformational characterization by NMR spectroscopy

Synthesis of novel pyrazolo[3,4-b]quinoline-Bisphosphonic acids and unexpected intramolecular cyclization and phosphonylation reaction

Water mediated and Baker yeast accelerated novel synthestic prtocols for tetrahydrobenzo[a]xanthene -11-ones and pyrazolo[3,4-b]quinolones

The synthesis of benzo[h]quinolones as topomerase inhibitors

Qunatum chemical studies and dyeing performance of some novel benzoquinoline based heterocyclic monoazo dyes on polyester fiber

Synthesis of heterocyclic monoazao dyes derived from 1H-benzo[g]pyrazolo[3,4-b]quinoline-3-ylamine: Their antimicrobial activity and their dyeing performance on various fibers

]quinoline derivative circumvents multi-drug resistance and causes apoptosis in colon cancer cells

Synthesis of 1H-pyrazolo[3,4-b]pyridine and related compounds

An object oriented synthetic approach toward angular and linear fused pyrazoloquinolines of biological importance with InCl 3 catalyst

2-Heterylquinoline derivatives

Synthesis of novel pyrazolo[3,4-b]quinolinyl acteamide analogs, their evaluation for antimicrobial and anticancer activities, validation by molecular modelling and COMFA analysis

3-Acetl-4-methylthiquinolin-2(1H)-one as useful synthon intermediate for synthesis of some new quinolinones

Substituted quinolinones.27. Regioselctive synthesis of pyrazolo-, oxazolo-, and trazepinoquinoline derivatives

Reaction of α-oxoketene-N,S-arylaminoacetals with Vilsmeier Reagents: An efficient route to highly functionalized quinolones and their benzo/hetero-fused analogues

Microwave-assisted, facile route to 1H-pyrazolo[3,4-b]quinolines

Palladium catalysed amino group arylation of 1,3-disubstituted-1H-pyrazolo-5-amine based on Buchwald-Hartwig reaction

Studies in the Vilsmeier-Haack reaction: Part XII. Synthesis of the 2-phenylpyrazolo[3,4-b]quinoline system

Synthesis of 1,3,6-trisubstituted -1H-pyrazolo[3,4-b]quinolines based on intramolecular condensation of 5-N-aryl-1H-pyrazole-5-amine derivatives

Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia

The discovery of potent, selective, and orally active pyrazoloquinolines as potent PDE10A inhibitors for the treatment of Schozophrenia

Pyrazoloquinolines as PDE10A inhibitors: Discover of a tool compound

The preparation of 9-hydroxypyrazolo[3,4-b]quinolines

Derivatives of 2-pyrazolin-5-one.V. Preparation and properties of 1 ,2 -dihydrospiro

Synthesis of oxazolo[5,4-b]quinoline through a nitrene intermediate

Studies on heterocyclic chemistry. Part XVI. Reaction of 4-o-nitrobenylidene -∆ 2 -pyrazoli-5-ones with trialkyl phosphites: Synthesis of phosphorus-substituted pyrazolo[3,4-b]quinoline derivatives

Condensation of 2-nitrobenzaldehyde with pyrazolin-5-ones. Structure of 4-(2-nitrobenzylidene)pyrazolin-5-ones and their reductive cyclization

The synthesis of 4-(o-fluorohenyl)-6,8-dihydro-3,8-dimethyl-pyrazolo

A diversity oriented synthesis of pyrazolo[4,3-f ]quinoline derivatives with potential biactivities via microwave-Assisted multicomponent reactions

Synthesis of quinoline derivatives by multicomponent reaction using niobium pentachloride as Lewis Acid

Multicomponent reactions for the synthesis of heterocycles

Aminoazoles as key reagents in multicomponent heterocyclizations

Syntheses of 4-Aryl-4,7,8,9-tetrahydro-6H-pyrazolo[3,4-b]quinolin-5-ones

quinolin-5(6H)-ones. Mechanism and structural analysis

L-Proline as an efficient enatioinduction organocatalyst in the solvent-free synthesis of pyrazolo[3,4-b]quinoline derivatives via one-pot multicomponent reaction

A multicomponent, facile and catalyst-free microwave-assisted protocol for the synthesis of pyrazolo[3,4-b]quinolines under green conditions

A green, efficient protocol for the catalyst free synthesis of tetrahydro-1H-pyrazolo[3,4-b]quinolin-5(4H)-ones supported by ultrasonicirradiation

Convenient regioselctive reaction in presence of H 3 PW 12 O 40 : Synthesis and characterization of pyrazolo[3,4-b]quinoline-3,5-diones

Triethanoloamine lactate-supprted nanomagnetic cellulose: A green and efficient catalyst dor the synthesis of pyrazolo[3,4-b]quinolines and theoretical study

Three-component one-pot synthesis of pyrazolo[3,4-b]quinolin-5(6H)-one derivatives in aqueous media

Polyethlene glycol (PEG-400): An efficient and recyclable reaction medium for the synthesis of pyrazolo

Facile synthesis of 4-aryl-1H-pyrazolo[3,4-b]quinolines

Synthesis of 1,3,4-triphenyl-1H-pyrazolo[3,4-b]quinoline derivatives under microwave irradiation

Facile one-pot multicomponent synthesis of 1H-pyrazolo[3,4-b]quinolones using L-proline as a catalyst

A new rapid multicomponent domino reaction for the foramtion of functinalized benzo

L-Proline-Catalysed sequential four component "on water" protocol for the synthesis od structurally complex heterocyclic ortho-quinones

Microwave induced three-component synthesis and antimicrobacerial activity of benzopyrazolo[3,4-b]quinolindiones

One-pot, three-component synthesis of polyfunctionalized benzo

Multicomponent synthesis of styryl linked benzo[h]pyrazolo[3,4-b]quinoline-5,6(10H)-diones by liquid assisted grinding

Microwave-Assisted one pot synthesis in water carbonylpyrazolo[3,4-b]pyridine derivatives catalysed by InCl 3 and sonochemical assisted condensation with aldehydes to obtain new chalcone derivatives containing the pyrazolpyridinic moiety

Aqua mediated indium(II) chloride catalysed synthesis of fused pyrimidines and pyrazoles

Synthesis of 4-aryl-3-methyl-1-phenyl-1H-benzo[h]pyrazolo[3,4-b]quinoline-5,10-diones using diammonium hydrogen phosphate as an efficient and versatile catalyst in water

PEG 1000 -Based dicationic acidic ionic liquid catalysed one-pot synthesis of 4-aryl-3-methyl-1-phenyl-1H-benzo[h]pyrazolo[3,4-b]quinoline-5,10-diones via multicomponent reactions

Proline catalysed multicomponent reactions: Facile access to 2H-benzo[g]pyrazolo[3,4-b]quinoline-5,10(4H,11H)-dione derivatives

]derivatives using wet cyanuric chloride under solvet free condition

Organic reaction in water: A highly efficient and environmentally friendly synthesis of spiro compouns catalysed by L-proline

H)-dione derivatives in aqueous medium

]quinoline-1,2-dione using Fe 3 O 4 @Cu(OH) x as Nanaocatalyst

Regioslective synthesis of fused benzopyrazolo[3,4-b]quinolines under solvent-free conditions

]pyridine with high fluorescence and their photophysical properties

DMSO as a methine source in TFA-mediated one pot tanden regioselctive synthesis of 3 substiuted -1-aryl-1H-pyrazolo[3,4-b]quinolines from anilines and pyrazolones

Quantum chemical ci-1 analysis of uv absorption spectra of 1h-pyrazolo[3,4-b]quinoline system

Optical absorption of 1H-pyrazolo[3,4-b]quinoline and its derivatives

New-synthesized pyrazoloquinoline as promising luminescent materials

Optical absorption of 1-phenyl-3-methyl-1H-pyrazolo[3,4-b]quinoline derivatives: Molecular dynamics modeling

Photoluminescence of 1,3-dimethyl pyrazoloquinoline derivatives

Photoluminescence of 1-phenyl-3-methyl pyrazoloquinoline derivatives

A novel near-infrared-emitting cyclometalated platinum (II) complex with donor-acceptor-acceptor chromophores. Dyes Pigment

Small Donor-Acceptor Molecules Based on a Quinoline-Fluorene System with Promising Photovoltaic Properties

Quinoline-based azo derivative assembly: Optical limiting property and enhancement mechanism. Dyes Pigment

Theoretical-Experimental Photophysical Investigations of the Solvent Effect on the Properties of Green-and Blue-Light-Emitting Quinoline Derivatives

Non-aggregating solvatochromic bipolar benzo[f]quinolines and benzo[a]acridines for organic electronics

Fluorescent quinoline carboxylate derivative: Study on the optical properties and photo diode application

Synthesis and Electrochemical Properties of 2,6-Bis(quinoline-2-yl)pyridyl Ruthenium Complexes as Near-Infrared Sensitizers for Dye-Sensitized Solar Cells

Pyrazole based NLOphores: Synthesis, photophysical, DFT, TDDFT studies. Dye. Pigment

Versatile optical materials: Fluorescence, non-linear optical and mesogenic properties of selected 2-pyrazoline derivatives

Rapid One-Pot, Four-Step Synthesis of Highly Fluorescent 1,3,4,5-Tetrasubstituted Pyrazoles

One-Pot Coupling-Coupling-Cyclocondensation Synthesis of Fluorescent Pyrazoles

3-Formylpyrazolo[1,5-a]pyrimidines as Key Intermediates for the Preparation of Functional Fluorophores

Effective electroluminescent materials for OLED applications based on lanthanide 1.3-diketonates bearing pyrazole moiety

Investigations of the Optical and Thermal Properties of the Pyrazoloquinoline Derivatives and Their Application for OLED Design

Synthesis of Fluorescent 1,7-Dipyridyl-bis-pyrazolo[3,4-b:4 ,3 -e]pyridines: Design of Reversible Chemosensors for Nanomolar Detection of Cu 2+

Pyrazolo-fused 4-azafluorenones as key reagents for the synthesis of fluorescent dicyanovinylidene-substituted derivatives

Synthesis of Functionalized Thiophene Based Pyrazole Amides via Various Catalytic Approaches: Structural Features through Computational Applications and Nonlinear Optical Properties

Fluorescent styryl chromophores with rigid (pyrazole) donor and rigid (benzothiophenedioxide) acceptor-Complete density functional theory (DFT), TDDFT and nonlinear optical study

Second-order optical effects in several pyrazoloquinoline derivatives

Optical properties of new pyrazolo[3,4-b] quinoline and its composites

Synthesis and Spectroscopic Study of Several Novel Annulated Azulene and Azafluoranthene Based Derivatives

Intramolecular Charge Transfer: Theory and Applications

Structural Changes Accompanying Intramolecular Electron Transfer: Focus on Twisted Intramolecular Charge-Transfer States and Structures

Some spirobiindane based 1H-pyrazolo[3,4-b] quinoline chromophore as novel chromophore for light-emitting diodes

Spectral properties of 1H-pyrazolo[3,4-b]quinoline substituted with N,N-diethylamine moiety

Photoinduced charge separation via twisted intramolecular charge transfer states. In Electron Transfer I. Topics in Current Chemistry

Dual fluorescence of donor-acceptor molecules and the Twisted Intramolecular Charge Transfer (ICT) states

Electronic structure of aromatic π-electron systems as reflected in their MCD spectra

Rational Design Principle for Modulating Fluorescence Properties of Fluorescein-Based Probes by Photoinduced Electron Transfer

Photoinduced Electron Transfer

Rigidization, preorientation and electronic decoupling-the 'magic triangle' for the design of highly efficient fluorescent sensors and switches

Towards Color Stable Blue Primary for Displays: Suppress Field-Dependent Color Change in a Multilayered Electroluminescent Device

Green electroluminescence from azafluoranthene derivatives in polymer based electroluminescent devices

Thermo-optical properties of 1H[3,4-b] quinoline films used in electroluminescent devices

Pyrazoloquinoline derivatives as efficient blue electroluminescent materials

Kityk, I.V. 4-(p-N,N-Diarylphenyl)substituted 1H-pyrazolo[3,4-b]quinolines as novel luminophors for organic light emitting diode-synthesis, electroluminescent devices

Applications of Fluorescent Sensor Based on 1H-pyrazolo[3,4-b]quinoline in Analytical Chemistry

New Fluorescent Sensors Based on 1H-pyrazolo[3,4-b]quinoline Skeleton

A New Fluorescent Sensor Based on 1H-pyrazolo[3,4-b]quinoline Skeleton. Part 2

Amino derivatives of 1,3-diphenyl-1H-pyrazolo[3,4-b]quinoline-Photophysics and implementation of molecular logic switches. Dyes Pigment

Stimuli-Responsive Thermally Activated Delayed Fluorescence in Polymer Nanoparticles and Thin Films: Applications in Chemical Sensing and Imaging

Fluorescence and photoinduced proton transfer in the protolytic forms of fluorescein: Experimental and computational study

An ICT-based fluorescence enhancement probe for detection of Sn 2+ in cancer cells

Recent advances in twisted intramolecular charge transfer (TICT) fluorescence and related phenomena in materials chemistry

Fluorescence umpolung enables light-up sensing of N-acetyltransferases and nerve agents

Introductory Heterocyclic Chemistry

A Review on Recent Advances in Nitrogen-Containg Molecules and Their Biological Applications

Prescribed drugs containing nitrogen heterocycles: An overview

Dialkylamino Alkylamino Pyrazolo (3,4b) quinolines. U.S. Patent 3600393A

The interferon system: An overview

Interferoninducer antivirals: Potential candidates to combat COVID-19

BL-20803, a New, Low-Molecular-Weight Interferon Inducer

Target Cells for Interferon Induction by BL-20803

Simulation of Interferon Production in Mice and in Mouse Spleen Leukocytes by Analogues of BL-20803

Antiviral Activity of BL-3849A, a Low-Molecular-Weight Oral Interferon Inducer

Připrava některých 4-anilino-1,3-dimetyl-1H-pyrazolo(3,4-b)chinolinů s protivirovým účinkem

Syntheses of 1, 2, and 9-methyl derivatives of 4,9-dihydro-3-methyl-4-oxo-1H(2H)-pyrazolo[3,4-b]quinoline and their antiviral activity

Připrava některých 4-fenoxy-a 4-fenylotioderivátů 1H-pyrazolo/3,4-b/chinolinu s protivirovým účinkem

Připrava některých 1-substituivaných 4-dialkylaminoalkylamino-3-metyl-1H-pyrazolo/3,4-b/chinolinů s protivirovým účinkem

Připrava 4-(hydroxyanilino)-a4-(alkoxyanilino)derivátů 1,3-dimetyl-1H-pyrazolo/3,4-b/chinolinu s potenciálním protivirovým účinkem

Připrava některých 1-substituivaných 4-alkylamin-3-metyl-1H-pyrazolo(3,4-b)chinolinů s potenciálním protivirovým účinkem

Syntheses of 1, 2, and 9-methyl derivatives of 4,9-dihydro-6-methoxy-3-methyl-4-oxo-1H(2H)-pyrazolo[3,4-b]quinoline and 4,9-dihydro-6-hydroxy-3-methyl-4-oxo-1H(2H)-pyrazolo[3,4-b]quinoline and their antiviral activity

Synthesis and biological activity of some basic-substituted 4,9-dihydro-3-methyl-4-oxo-1H(2H)-pyrazolo[3,4-b]quinolines. Coll

Substituované 4-anilino-1,3-dimethyl-1H-pyrazolo/3,4-b/chinoliny a Způsoby Jejich Přípravy

Substituované 4,9-dihydro-3-methyl-4-oxo-1H-pyrazolo(3,4-b)chinoliny a Spůsob Jejich Výroby

Substituované 4-fenoxy-3-methyl-1H-pyrazolo(3,4-b)chinoliny a Způsoby Jejich Přípravy. CS Patent 235176B1

Zelená, D. 4-Karboxyalkylamino-1,3-dimethyl-1H-pyrazolo(3,4-b)chinoliny a Způsob Jejich Přípravy

4-Chlor-6-methoxy-3-methyl-1H-pyrazolo(3,4-b)chinolin a Jeho N1-methylderivát

4-b)chinoliny. CS Patent 252341B1

9-dihydro-6-methoxy-3-methyl-4-oxo-1H-pyrazolo(3,4-b)chinolin. CS Patent 252621B1

Homology modeling, binding site identification, and docking study of human β-arrestin: An adaptor protein involved in apoptosis

Pharmacophore-based identification and in vitro validation of apoptosis inducers as anticancer agents

Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents

4-Substituted Pyrazoloquinoline Derivatives

SCH 43478 and analogs: In vitro activity and in vivo efficacy of novel agents for herpesvirus type 2

Synthesis of Aldehydo-sugar Derivatives of Pyrazoloquinoline as Inhibitors of Herpes Simplex Virus Type 1 Replication

Evaluation of Some Pyrazoloquinolines as Inhibitors of Herpes Simplex Virus Type 1 Replication

Evaluation of Cytotoxic Potential of Newly Synhtesized Antivirial Aminopyrazoloquinoline Derivatives

Cytotoxic and genotoxic potentials of newly synthesized antivirial aminopyrazoloquinoline derivatives

Heterocyclic Compounds That Inhibit Rev-RRE Function and Human Immunodeficiency Virus Type 1 Replication

Multidrug-resistant, extensively drug-resistnat and pandrug-resistant bacteria: An international expert propos al for interim standard definitions for acquired resistance

Synthesis and Antimicrobial Activity of Novel Pyrazolo[3,4-b]quinoline Derivatives

Regioselective acylation of congeners of 3-amino-1H-pyrazolo[3,4-b]quinolines, their activity on bacterial serine/threonine protein kinases and in vitro antibacterial (including antimycobacterial) activity

Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?

Effiacy, safety, and cost of new anticancer drugs

]quinoline-3-amine derivatives inhibit growth of colon cancer cells via apoptosis and sub G1 cell cycle arrest

]quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells

The Molecular Perspective: The ras Oncogene

Targeting RAS signaling pathways in cancer therapy

SCH 51344 Inhibits ras Transformation by a Novel Mechanism

SCH 51344-induced reversal of RAS-transformation is accompanied by the specific inhibition of the RAS and RAC-dependent cell morphology pathway

An Inhibitor of RAS/RAC-Mediated Cell Morphology Pathway

Inhibition of RAS-transformation by SCH51344

Reexpression of the Major PKC Substrate, SSeCKS, Correlates with the Tumor-Suppressive Effects of SCH51344 on Rat-6/src and Rat-6/ras Fibroblasts but Not on Rat-6/raf Fibroblasts

Stereosceific targeting of MTH1 by (S)-crizotinib as an anticancer strategy

Aminoheteroaryl Compounds as MTH1 Inhibitors. WO Patent

Hide and seek: Identification and confirmation of small molecule protein targets

SCH 51344

Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms

Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival

MutT Homolog 1 (MTH1): The Silencing of a Target

Combinatorial Pharmacophore-Based 3D-QSAR Analysis and Virtual Screening of FGFR1 Inhibitors

Aminoheteroaryl Compounds as MTH1 Inhibitors

Methods and Compositions for Reducing Interleukin-4 or Interleukin-13 Signaling

Synthesis and evaluation of pyrazolo[3,4-b]quinoline ribofuranosides and their derivatives as inhibitors of oncogenic Ras

Induction of Apoptosis by

Effect of Pyrazoloquinoline Derivatives on the Growth of Leishmania donovani Promastigotes

Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: A clinical review

Antipsychotic medication in schizophrenia: A review

Inhibition mechanism exploration of quinoline derivatives as PDE10A inhibitors by in silico analysis

A comparative study of binding affinities for 6,7-dimethoxy-4-pyrrolidylquinozalines as phosphodiesterase 10A inhibitors using the linear interaction energy method

Epidemiology of Type 2 Diabetes-Global Burden of Disease and Forecasted Trends

Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes

]quinoline-4-ones as novel, selective c-Jun N-terminal kinase inhibitors

Synthesis and Benzodiazepine Receptor Binding Activity of 2,9

Synthesis and Structure-Activity Relationship Studies in Translocator Protein Ligands Based on a Pyrazolo[3,4-b]quinoline Scaffold

Translocator protein (18 kDa): New nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

Diagnostic and Therapeutic Potential of TSPO Studies Regarding Neurodegenerative Diseases, Psychiatric Disorders, Alcohol Use Disorders, Traumatic Brain Injury, and Stroke: An Update

Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic

Scintillation Proximity Assays in High-Throughput Screening

Compounds Capable of Generating Singlet Oxygen Represent a Source of Artifactual Data in Scintillation Proximity Assays Measuring Phosphopeptide Binding to SH2 Domains

Pregnancy interceptive efficacy and biological profile of 3-amino-6,7-dimethyl-1H-pyrazolo[3,4-b] quinoline (compound 85/83) in rodents

The authors declare no conflicts of interst.